2012
ANNU AL RE VI EW & DI RECTORY
M E D I WA L E S I S S U P P O R T E D B Y T H E W E L S H G O V E R N M E N T
Your sterile single-use solution, without compromise
Our combination of high quality innovative products and exceptional levels of service provide supreme clinical value.
Specialities served: General and Vascular, ENT/MaxFax, Gynaecological, Neurosurgical and Orthopaedic
T: +44 (0)1792 797910
F: +44 (0)1792 797955 E: info@dtrmedical.com
www.dtrmedical.com Twitter: @dtrmedical 22
Annual Review & Directory 2012
Contents 4 9 10 13 14 16 18
Spotlight on Support Structure and Management Annual Review Summary Organisations of Interest MediWales’ Life Science Expert Advisory Group UK Life Science Event Calendar 2012-13 Members’ Directory
Introduction
Cyflwyniad
Our Annual Review and Directory summarises last year’s activity and highlights our goals for the next 12 months.
Mae’r Arolwg a Chyfeirlyfr Blynyddol yn crynhoi gweithgareddau llynedd ac yn uchafbwyntio ein targedau ar gyfer y 12 mis nesaf.
For this edition, several new sections have been added to aid stakeholders’ understanding and navigation of the life science sector.
Mae nifer o adrannau newydd wedi eu ychwanegu i’r Arolwg Blynyddol eleni, er llês ein budd-ddalwyr yn y sector gwyddoniaeth bywydol.
We have included a double-page calendar of Welsh, UK and international events to help our members plan for the coming year.
Rydym wedi cynnwys calendr tudalen ddwbl o ddigwyddiadau lleol, gwladol a rhwngwladol, er mwyn helpu ein aelodion i gynllunio am y flwyddyn nesaf.
Our ‘organisations of interest’ page provides useful contacts regarding business support, funding and international trade, among others. Lastly, our directory now organises members into academic, contract research and testing, charities, industry, and professional service sections to help you find appropriate contacts with ease. We hope this edition becomes an invaluable resource.
Jess Fisher
Editor
Mae’r dudalen ‘sefydliadau o ddiddordeb’ yn cynnwys cysylltiadau ddefnyddiol ynglyˆn â chymorth busnes, cyllid a masnachu rhwngwladol, ymysg eraill. Yn olaf, mae’r cyfeirlyfr bresennol yn trefnu aelodion i mewn i ddosrannau academaidd, ymchwil a phrofi contractau, elusennau, diwydiannol a gwasanaethau broffesiynol er mwyn gwneud hi’n haws ddarganfod y cysylltiadau mwyaf addas i’ch anghenion unigol. Gobeithiwn byddwch yn ystyried yr Arolwg Blynyddol yma yn adnodd gwerthfawr i eich anghenion broffesiynol.
Jess Fisher Golygydd
Gwyn Tudor Forum Manager: gwyn.tudor@mediwales.com
7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ Tel: +44 (0)29 2047 3456 Web: www.mediwales.com
CO R P O R AT E S P O N S O R S
Debbie Laubach Operations Manager: debbie.laubach@mediwales.com Jessica Fisher Communications Manager: jess.fisher@mediwales.com Ruth Campbell Project Coordinator: ruth.campbell@mediwales.com
22
Spotlight on Support MediWales has been listening and the message from our stakeholders is simple: Welsh life science is resilient but organisations need continued support to thrive and sell their offering to the world. In order to do this, three types of support are needed: access to finance, clinical expertise, and international trade assistance. MediWales has been working with Welsh and UK organisations to ensure our members receive this support.
Developing the Welsh brand Selling Wales abroad extends beyond the individual company. MediWales has been working with the Welsh Government and our Life Science Expert Advisory Group (LSEAG) to succinctly voice what makes Wales unique as a place to work in life sciences.
We are small – the proximity between organisations means we can network easily and quickly. We are devolved – giving us the power to work on Welsh-specific sector needs. We have a devolved NHS – allowing for faster permissions for testing and trials and improving access to clinical expertise. Anonymised healthcare data for the whole population means that clinical trials can
access 3 million people, with a single coordinated permissions process. Having a life science sector of significant value to the Welsh economy gives us the ear of our ministers, who work closely with us to enable growth. We have a dedicated Welsh Government Life Science Team to help companies and academia develop.
Funding Recently Edwina Hart, announced the £100 million Welsh Life Sciences Fund.
Having a strong brand identity in Wales is a great asset, however for organisations to succeed, consider relocating to Wales, or start up here, access to funding is vital.
Welsh Government In the past year both detailed strategy documents and significant investment has been made available by the Welsh Government to boost the sector’s growth. The Chief Scientific Officer for Wales has published ‘Science for Wales’, detailing the vision and initiatives that will be taken to enhance life sciences - among other science
4
sub-sectors. The strategy includes an additional £50 million for science R&D in Welsh universities over the next five years. The Wales Economic Growth Fund launched in December 2011 has funded several companies to date, including our own valued members Biotec Services International. There is also the Wales SME Investment Fund, where £40 million will be invested in Welsh companies over the next four years. At BioWales 2012, the Minister for Business, Enterprise, Technology and Science, Edwina Hart, announced the £100 million Welsh Life Sciences Fund – a dedicated equity fund.
The Welsh Government currently invests over £40 million in NHS Wales R&D every year. This Welsh Life Sciences Fund will complement this investment, helping keep commercial outcomes from funded R&D in Wales.
£100m
Recently Edwina Hart announced the £100 million Welsh Life Sciences Fund.
Annual Review & Directory 2012
MediWales Our event held in March 2012 highlighted the current landscape in Wales and the UK for accessing finance and funding for projects. The UK Government’s Department for Business Innovation & Skills’ £180 million Biomedical Catalyst fund was discussed, along with the National Institute for Social Care and Health Research (NISCHR) Academic Health Science Collaboration’s (AHSC) recently agreed
plans to support and enhance collaboration between industry and the NHS in Wales. Speakers from the Wellcome Trust, Technology Strategy Board, invention 4 innovation and FP7 programmes advised on how to find sources of funding for the translation of healthcare innovations into commercial products.
Investment fund managers from Finance Wales and Fusion IP, and a representative of the London Stock Exchange, advised on venture capital financing and investing for growth, with other presentations covering new tax incentives for R&D and the patent box scheme, innovation IP and the risks and benefits within collaborations.
Visit our website, www.mediwales.com/event/mw-f&f-presentations to access the full presentations from this event.
5
International trade Our members have expressed the desire to increase their international trade effort. Organisations small and large, from startups to global subsidiaries, are looking at new and/or existing markets and need support to improve their global business links.
MediWales Our International Trade event on 3 July 2012 gave an introduction to the international life science trade missions 2012-13, and detailed the funding and business support available from various organisations. Paul Benton from the Association of British Healthcare Industries (ABHI) spoke about their influence on trade policy; their ability to introduce industry to customers and policy makers; and their market intelligence, including market reports. Cari-Anne Quinn from the Welsh Government - Life Sciences Team announced the Welsh-led missions and the new International Trade Development Programme (ITD) for both new and experienced exporters, and their International Trade Opportunities Programme (ITO) for export ready businesses.
Announced recently, the Welsh Government is supporting businesses to attend the following missions between 2012-13: 1-3 October 2012
Advamed, Boston, USA
18-21 October 2012
China International Medical Equipment Fair, China
30 October – 2 November 2012
AusBio, Melbourne, Australia
14-17 November 2012
Medica, Dusseldorf, Germany
28-31 January 2013
Arab Health, Dubai, UAE
April 2013
China International Medical Equipment Fair, Shenzhen, China
A range of financial and business support will be provided - both Welsh Government and MediWales will circulate details of this in due course.
UK Trade & Investment UK Trade and Investment (UKTI) has also announced the trade missions they are supporting with a delegation. They recently published ‘Preparing to export: ten key steps’, a guide for potential exporters on how to enter new markets, detailing what support UKTI can give companies along the way:
1. Review your export potential 2. Develop an action plan 3. Research and prepare to visit the market
Graham Morgan from the Chamber of Commerce gave a comprehensive overview of the support they provide, including country briefs, freight operator signposting, and export finance.
4. Explore routes to market entry
UKTI Sector Specialist for Healthcare and Medical Technology at UKTI, Kevin Wilson, gave an overview of potential countries to trade with and the support UKTI can give.
8. Prepare to protect your intellectual property
Visit our website to download the event’s presentations: www.mediwales. com/news/mw-ite-presentations
6
Welsh Government
5. Find out about selling and marketing your product overseas 6. Think about cultural and linguistic challenges 7. Prepare to manage finance, payment and risk 9. Prepare to fulfill your orders and get your documentation right 10. Choose your distribution, shipping and delivery methods There are different levels of support available depending on the international trade experience the company has. For full details of UKTI and Welsh Government supported missions, please refer to our calendar on pages 16-17.
Annual Review & Directory 2012
Consistent collaboration In an effort to promote the Welsh life science brand, widen the net of potential collaborators and investors for our members, and increase our sources of intelligence, MediWales teams up with other organisations to hold joint events. This year we provided BioWales 2012 with marketing support to promote the conference to delegates outside of Wales. Our extensive relationships with Medilink UK and other life science networks including the ABHI, One Nucleus, South East Health Technologies Alliance (SEHTA), and the HealthTech and Medicines Knowledge Transfer Network (KTN), allowed for great reach and uptake at the event. To ensure our members can take advantage of support outside of Wales, we collaborated with the ABHI to hold an event in Wales where they explained their role in life sciences. Providing support for members in diagnostics, we held a collaborative event with the Technology Strategy Board on their funding call for the Detection and Identification of Infectious Diseases, giving advice on how to apply. We have several more collaborative events in the pipeline for the coming year and would welcome comments and suggestions on topics from our members and stakeholders.
Bridging the gap between the NHS and industry The necessity for funding calls and research and development (R&D) to include collaboration between industry, academia and the NHS has long been discussed. Over the past year, NISCHR has worked with the NISCHR Academic Health Science Collaboration (AHSC) to develop a programme of work to facilitate greater opportunities for collaboration between industry and the NHS in Wales. NISCHR AHSC’s Industry Task and Finish Group provided a number
of recommendations, which now underpin this programme of work. These recommendations broadly cover: implementing a communications plan, focusing on marketing Wales through the Health Research Wales brand as a conducive environment for industry to collaborate in health research; providing a sign-posting and facilitation service to industry to assist in identifying new partner sites and fostering new relationships; and providing better access to funding schemes enabling proof of concept studies to be undertaken rapidly in the NHS in Wales. In order to implement all of the recommendations fully, an industry team is being recruited, which will include three Industry Managers working on a regional basis for Wales. These individuals will be a point of contact for industry and will deliver the Health Research Wales service, supporting the successful initiation and delivery of commercial research in Wales. The NISCHR R&D NHS funding plan emphasises the importance of industrial collaborations by broadening the use of R&D allocations to include commercial contract research. The Innovation agenda is a cross cutting theme for Welsh Government and a number of initiatives are addressing how new innovations can be taken up at scale and pace by the NHS. Within this remit, a NISCHR’s Innovation Task and Finish Group has recently been set up to address
innovation and intellectual property management within the NHS, with a specific focus on ‘inventions’. NISCHR has also provided a review of the Innovation, Health and Wealth report published by the Chief Executive of NHS England to senior Welsh Government officials and outlined the significant role the NHS plays in the adoption and uptake of new technologies.
Increased member support Launched over a year ago, MediWales’ website has provided an invaluable tool for members. We promote members’ and other organisations’ news, events, and opportunities (collaborative projects and jobs) through the website, our Twitter feed and our LinkedIn MediWales group. Our funding and finance and clinical access pages have been added to signpost members to appropriate contacts. Just launched, our enhanced member profiles aim to join up the dots: profiles include a company’s logo, google map of their location, twitter feed, company linkedin profile, and all their news, events, and opportunities located on one page. For more information about promotional opportunities through the MediWales network please contact info@mediwales.com. Through email, the website, phone and face to face, MediWales will keep its members and wider stakeholders up to date with the latest sector developments and opportunities.
7
Welsh Government Business Support Packages In Wales we now have a full range of funding mechanisms, programmes and infrastructure to support businesses to grow, pursue R&D opportunities, develop international trade links, and capture and retain the value of any commercial activity in Wales.
“Wales has a fresh vision for the Life Sciences Sector and our focus is now clearly on business growth and commercial success.” Funding Mechanisms for Business Development in Life Sciences 1. Finance Options Life Sciences Wales Investment Fund – announced March 2012 l The Life Sciences Investment Fund is a dedicated equity fund, making equity and mezzanine investments into innovative Welsh life sciences businesses. The Fund will invest into businesses at all stages of growth, including seed capital funding. l The Fund has a target size of £100 million and will be operated on a commercial basis with a dedicated investment panel and fund management team - experienced life sciences investors with a proven track record of success at an UK and global level.
3. Business Innovation Support l Innovation, R&D and new product development advice. l Manufacturing and design advice. l Innovation Vouchers - funding for third-party consultancy for product development and process management. l Support available from technical feasibility through to commercialisation stage. l Funding is available for Research, Development and Innovation clinical trials for phase 0 (first into human) and phase 1 (up to 80 patients) subject to a financial cap.
l It is anticipated that first investments will be made this year.
l Funding to support academic collaboration opportunities.
Business Finance
4. Skills and Employee Development
l This finance option is available for growth capital projects and to aid job creation as well as for projects involving research, development and innovation.
l Workforce Development Programme and Skills Growth Wales schemes provide advice from HR development advisers and funding towards some employee training costs.
2. Trade and Export Development l International Trade Development (ITD) - consultancy support is available to help new exporters develop export capabilities, which is free of charge to businesses. l International Trade Opportunities (ITO) - support is available from in-market contractors to identify opportunities and potential overseas customers for companies who are exportready or targeting new customers - businesses pay 25% of the project costs (75% subsidy provided by Welsh Government). l Trade Missions - organised support for exhibitor stands within a Wales group area at selected overseas trade exhibitions.
5. ICT and eBusiness support l The ICT Diagnostic Service - a systems healthcheck, where an expert provides recommendations for improvement at no cost to the client. l eBusiness support – subsidised support to identify and projectmanage ICT solutions.
The business development team from the life sciences sector can guide and support companies in accessing the relevant support.
For further information please contact the Life Sciences Team in the Business, Enterprise, Technology and Science (BETS) department: tel: 03000 603000 or email : lifesciences@wales.gsi.gov.uk
Annual Review & Directory 2012
Structure and Management The Team:
Directors:
Gwyn Tudor, Forum Manager:
Mr Greg Baily – MediWales Chairman, Huntleigh (Part of the Getinge Group) Huntleigh designs, manufactures and globally distributes a wide range of medical devices. These include pressure relieving surfaces, wound treatment, bedframes, patient monitors, DVT prevention, lifts and hoists.
Dr Catherine Ramsay, 3M Microbiology 3M Microbiology in Bridgend is a leading manufacturer of rapid hygiene testing and microbial screening products for use in a wide range of manufacturers from food to toiletries, and for other applications including hospital hygiene and biodetection systems for defence agencies.
Andrew Davidson, DTR Medical DTR Medical is an innovative medical device and cleanroom contract manufacturer with the ability to design, CE mark, manufacture and sterilise a wide range of healthcare products. DTR Medical sells and markets its own brand of sterile single-use surgical instruments for ENT, Vascular, Neurology, Orthopaedic and general surgery.
Professor Paul J Smith, School of Medicine, Cardiff University The Cancer Biology and Biophotonics group encompasses basic cellular research, systems biology anticancer drug discovery and leads the UK Optical Biochips Consortium, developing microand nanotechnologies for the life sciences.
Responsible for strategic direction, business planning and representative roles with Welsh and UK bodies.
Debbie Laubach, Operations Manager: Responsible for project management, company liaison, events, the life science advisory group and the clinical access initiative.
Jessica Fisher, Communications Manager: Editor of the MediWales Review and UK Life Sciences Industry Magazine; responsible for membership services, project management, the MediWales website and social media.
Ruth Campbell, Project Coordinator: Responsible for advertising and production of the MediWales Review, membership services, and events organisation.
Professor David Ford, College of Medicine, Swansea University The College of Medicine at Swansea University is Wales’ second medical school. It runs as an innovative graduate entry medical programme, and undertakes a wide range of biomedical, clinical and population research, supported by high-performance supercomputing. Dr Paul Michael, GE Healthcare GE Healthcare is a world leader in medical diagnostics and life sciences. Focussed on enabling molecular medicine, the company works through business areas in diagnostic imaging, protein separations, consumables and cellular technologies.
Andrew Thomas, Rogue Resolutions Rogue Resolutions is a collaboration between Rogue Research Inc (Brainsight), and neuroConn GmbH (DC-STIMULATOR, NEURO PRAX and THERA PRAX), providing integrated equipment solutions for neuroscience. Their portfolio of services and products already includes a range of ‘best-in-class’ devices. Chris Williams, Ig Innovations Ig Innovations offers bespoke antibody production and supply to the research, diagnostic, biotech and pharmaceutical sectors, including antigen design, peptide synthesis, conjugation, through to antibody purification, conjugation and assay development. Observers Welsh Government
9
Annual Review Summary Publications
11 events 50 speakers 500 attendees (up 30% on previous year)
5 magazines distribution of over 30,000 across the UK and abroad
Attendees up 30%
Events
(up 15% on previous year)
Membership Industry:
Representation and Direct Support
Web visits up 17%
Digital Communications Over 1,400 website visits per month (up 17% on previouss year) 12 e-newsletters 2,000 distribution namess
129 54
Clinical organisations:
9
Charities:
4
Professional Services:
42
Academic:
20
Website Average visits per month:
10
Distribution up 15%
PERFORMANCE 2011-12
1400
Twitter followers:
450
LinkedIn followers:
236
82 companies supported 18 site visits 67 events/meetings attended
Publications The Review:
2 x 3000 person distribution
Annual Review and Directory: UK Lifescience Industry Magazine:
1 x 3000 2 x 38,000
Annual Review & Directory 2012
MediWales Events
Delegates
Life Science Expert Advisory Group, Invacare UK, 12 May 2011
28
The University Challenge, 24 June 2011
70 15
Life Science Expert Advisory Group, GE Healthcare, 6 October 2011
41 17
Members’ Showcase, 12 October 2011 Life Science Expert Advisory Group’s Procurement Special Interest Group, 31 October 2011
250
MediWales’ Innovation Awards, 8 December Life Science Expert Advisory Group, Huntleigh, 21 February 2012
28
Funding and Finance Event, 22 March 2012
77 12
●
NISCHR- Advisory Board NISCHR AHSC – Implementation group NISCHR AHSC – Industry Task and Finish Group NISCHR Innovation – Task and Finish Group
UK Government - Department for Business, Innovation and Skills (BIS) ● Bioscience and Health Data Partners UK Government - UK Trade & Investment ● Regional stakeholder meetings Medilink UK ● Management Board Welsh Wound Network ● Management Committee Swansea University ● eHealth Industries Innovation (ehi2) Centre– Steering Group
Objectives 2012-13
Collaborative Events Glyndwr University’s Wrexham Science Festival
13 July 2011
SARTRE’s Diabetes Senior Researchers’ Meeting
18 October 2011
ASTUTE’s Enhancing Medical Manufacturing in Wales
31 January 2012
Medilink UK’s Health Technology Awards
●
●
31 26
Diagnostic Event, 7 September 2011
ABHI’s and MediWales’ Welsh Regional Event
Welsh Government ●
Life Science Expert Advisory Group’s Procurement Special Interest Group, 19 July 2011
Life Science Expert Advisory Group’s Wales Life Science Sector Branding Meeting, 26 March 2012
Representation on UK Boards
21 February 2012 13 March 2012
1 Work to accelerate market entry for
members’ new innovative products and services
2 Support sales of members’ products and services in the UK and abroad
3 Improve vital communication channels
between industry, clinicians and academia
4 Build upon successful networks across the UK to represent the interests of member companies
5 Consolidate MediWales’ position as the
primary source of intelligence and point of contact within Welsh life science
6 Support the Welsh Government’s efforts to grow the sector as a whole
7 Support the Welsh Government’s efforts to leverage investment into the sector
8 Ensure a successful and sustainable future for MediWales
11 9
The Design Engineers behind the Detectives, developing a forensic casework analyser that’s fast, low cost and highly accurate. We solved it, with the analysis system that delivers early DNA intelligence to law enforcement and security agencies.
Our Services: Electronics Industrial Design Mechanical Engineering Software Design Rapid Prototyping Optronics Value Engineering Specialist Areas Regulatory Support GPS/GPRS Tracking SCADA/PLC Systems
Ever had a brilliant idea that you know could succeed… if only someone could turn it into a commercial reality? It’s what we do. As one of the UK’s leading technology and innovation companies we take a multidisciplinary and holistic approach to turn brilliant ideas into commercial realities.
We combine these capabilities with creativity, experience and absolute problem solving intelligence to deliver solutions that are innovative, commercial and practical.
We are fascinated by the challenges presented by imaginative clients and offer a complete skill set for product development. This includes electronic hardware and software design, industrial and mechanical engineering plus specialist areas such as optronics and microfluidics.
Whether it’s a low cost rapid DNA device for analysing forensic casework samples, or all manner of medical, scientific or instrumentation projects, we make it possible.
www.gxgroup.com | +44 (0) 1291 673 437
22
Make it possible
Annual Review & Directory 2012
Organisations of Interest UK/Regional Partners and Networks:
International Trade:
Medilink UK +44 (0)121 452 5630 www.medilinkuk.com
Welsh Government - Life Sciences Team, lifesciences@wales.gsi.gov.uk, +44 (0)3000 603000
HealthTech and Medicines Knowledge Transfer Network Narpal Sihra, Senior Marketing Manager, narpal.sihra@healthktn.org, +44 (0)20 3402 3316 www.innovateuk.org/healthktn Association of British Healthcare Industries Daniel Jones, Communications Director, daniel.jones@abhi.org.uk, +44 (0)20 7960 4360 www.abhi.org.uk One Nucleus Tony Jones, Director of Business Development, tony@onenucleus.com, +44 (0) 1223 896 463 www.onenucleus.com
UK Trade & Investment (UKTI) John Lownds, UKTI Life Sciences, john.lownds@ukti.gsi.gov.uk, +44 (0)20 7215 8086
International Missions 2012-13 Medica www.medica-tradefair.com AdvaMed www.advamed2012.com Bio www.convention.bio.org Arab Health www.arabhealthonline.com Hospitalar www.hospitalar.com/ingles CMEF www.cmef.com.cn/en/index.html
Business Support: Welsh Government - Life Sciences Team, lifesciences@wales.gsi.gov.uk, +44(0)3000 603000
NHS and Research Organisations: National Institute for Social Care and Health Research (NISCHR) - Academic Health Science Collaboration (AHSC) Manager, Alex Hills, alex.hills@wales.nhs.uk,, +44 (0)29 2019 6822 www.nischr-ahsc.org.uk Medicines and Healthcare products Regulatory Agency (MHRA) www.mhra.gov.uk National Institute for Health Research (NIHR) www.nihr.ac.uk National Institute for Health and Clinical Excellence (NICE) - Lee Dobson, Notifications & External Engagement Manager - Medical Technologies Evaluation Programme, National Institute for Health and Clinical Excellence, lee.dobson@nice.org.uk +44 (0)161 2193862 www.nice.org.uk/mt
Go Wales - placements, jobs and training. Marketing Team: info@gowales.co.uk, +44 (0)845 225 60 50 www.gowales.co.uk South Wales Chamber of Commerce, Graham Morgan, Director, graham.morgan@southwaleschamber.co.uk, +44 (0)1633 242720
Funding: Invention for Innovation (i4i) programme www.ccf.nihr.ac.uk/i4i Wellcome Trust www.wellcome.ac.uk/funding Technology Strategy Board National www.innovateuk.org Welsh Government www.wales.gov.uk/funding National Institute for Social Care and Health Research www.wales.nhs.uk/sites3/home.cfm?orgid=952 Department of Health/National Institute for Health Research www.ccf.nihr.ac.uk European Funding www.fp7uk.co.uk
13
MediWales’ Life Science Expert Advisory Group (LSEAG) Life science represents one of the priority sectors of the Welsh economy. A sector that creates high value manufacturing jobs, has global market potential, and is growing despite current financial conditions. Wales has significant strategic assets beneficial to this sector including excellent research activity, a devolved NHS, access to European markets, and an industry sector that already comprises a large number of global brands. Two years ago MediWales formed the Life Science
Through the quarterly meetings, the following topics have been raised and resulted in active projects: ● Picture of Health – a digital resource to showcase and connect different stakeholders in the Welsh sector ● Branding Wales – the development of an elevator pitch for Welsh life science to attract investors and potential re-locators ● Procurement – specialist breakout meetings
Expert Advisory Group. A consortium of experts
between industry, the NHS and Welsh
and senior personnel within the academic, business
procurement services to discuss the
and clinical life science communities in Wales, this
problems of innovation uptake
group advises MediWales on pressing issues within the sector. MediWales uses the group’s discussions to facilitate communication between appropriate parties in order to create change, advise Welsh Government, and to shape our own activities in terms of events, publications and membership support. The group actively improves the networking communications between the academic, business and clinical communities (ABC), identifying and addressing the future threats and opportunities for these stakeholder communities.
14
For more information about any of these projects, please contact:
debbie.laubach@mediwales.com
Annual Review & Directory 2012
Company / Organisation
Name
Title
3M Microbiology
Catherine Ramsay
Technical Specialist
Cardiff University
Paul Smith
Professor of Cancer Biology
DTR Medical
Andrew Davidson
Managing Director
GE Healthcare
Paul Michael
DFSS Black Belt, Lifecycle & Process Engineering
Huntleigh
Greg Baily
Technical Director
Ig Innovations
Chris Williams
Chief Operating Officer
Rogue Resolutions
Andrew Thomas
Managing Director
Swansea University
David Ford
University Director
Abertawe Bro Morgannwg UHB
Gemma Hughes
R&D Manager
Alere Connected Health
David Muxworthy
Director
Aneurin Bevan Health Board
Sue Bale
Assistant Nurse Director Research & Development
LSEAG - who’s who?
MEDIWALES DIRECTORS
LIFE SCIENCE ADVISORY PANEL
Bangor University
Mark Baird
Professor of Chemistry
Betsi Cadwaladr University Health Board
David Parker
Director of Research & Development
Betsi Cadwaladr University Health Board, Glan Clwyd Hospital
Patrick Hill
Deputy Director, North Wales Medical Physics
BioMonde
Gareth Kempson
Chief Executive Officer
Biotec Services International
Keren Winmill
Chief Executive
Cardiff & Vale NHS Trust
Jonathan Bisson
Research & Development Director
Cardiff University, RACD
Gareth Evans
Business Development Manager
Cardiff University, WAI
Judith Hall
Professor, Anaesthetics, Intensive Care and Pain Medicine, School of Medicine
Cardiff University, Wound Healing Research Unit Keith Harding
Sub Dean of Innovation and Engagement, School of Medicine
Cedar - University Hospital Wales
Grace Carolan-Rees
Director
CellPath
Peter Webber
Chairman
ConvaTec Global Development Centre
Jerry Hutchinson
Director, Human Physiology
Exopack
Kevin Schofield
Global Market Manager - Medical
Finance Wales
Melanie Goward
Senior Investment Executive
Frontier Medical Group
Nick Davis
Group Managing Director
Geldards LLP
Ceri Delamore
Partner, Commercial
Invacare
Huw Roderick
Business Development Manager
Microsemi
Martin McHugh
Business and Technology Development Manager
Microvisk
John Curtis
CEO
NHS Shared Services Partnership (WHS)
June Scott
Head of Contracting
Nightingale Care Beds
Kevin Eames
Business Development Manager
Norgine
Roger Jones
Site Director
Penn Pharma
John Roberts
Commercial & Manufacturing Director
Surgical Materials Testing Laboratory
Peter Philips
Director
Thermo Fisher Scientific
Rachel Adams
Marketing Manager
Wales Research & PET Imaging Centre
Chris Marshall
Operations Director
OBSERVERS Welsh Government
15
UK Life Science Event Calendar 2012-13 August 8-10
FIME 2012, International Mission, Florida, USA
27
Advamed US Mission, registration deadline (UKTI and WG Mission)
26-29
24th European Medical Informatics Conference - MIE2012, Italy
September 3
Wellcome Trust Health Innovation Challenge Fund (round 7), funding deadline
5
Medilink Seminar: CE Marking - An introduction to the Medical Devices Directive, Birmingham
9-13
UKTI: Wound Care, International Mission, China
12-13
Bio-India, International Mission, Mumbai, India
13
Medilink: Clinical Trials Seminar for Non-scientists, Birmingham
13
One Nucleus: Building Value in Medical Technology Companies Conference, Cambridge
19-20
Medilink EM Seminar: Risk Management of medical devices ISO 14971, Birmingham
19-20
15th MedTech Investing Europe Conference, London
20
HealthTech & Medicines KTN Seminar - Opportunities for Addressing Unmet Clinical Needs in Major Types of Cancer
19-21
Annual European Pressure Ulcer Conference, Cardiff
19-21
BioSpain, International Mission, Bilbao, Spain
25-26
TCT Live 2012 Conference: The International Forum for Product Development and Manufacturing, Birmingham
26
One Nucleus Seminar: Life Science Leadership Series - healthcare technologies, Cambridge
October
16
29-4
ABHI MedTech International Mission to Saudi Arabia (UKTI support)
1-3
Advamed Conference & Exhibition, Boston (UKTI and Welsh Government mission)
9-11
CPhI Worldwide, International Mission, Madrid
10-13
REHACARE, International Mission, Dusseldorf, Gerrmany
15-16
UKTI International Mission: Franco-British business exchange – challenges in personal care, Normandy, France
17
ABHI Conference: The Revision - MDD A definitive Overview, CBI Conference Centre, London
18-21
China International Medical Equipment Fair, Chengdu, China (Welsh Government Mission)
22
UKTI: Bio Mission, China
Annual Review & Directory 2012
November 8
ABPI Annual conference and dinner 2012 – Access all areas?, London
8
ABHI UDI Systems Seminar: The future has started, London
14-17
Medica 2012, Dussledorf, Germany (Welsh Government and UKTI Mission)
16
Stop Pressure Ulcer Day, The Senedd, Cardiff
27
ABHI UK Market Conference, London
28-29
HealthTech and Medicines KTN BioProcessUK Conference: Accelerating Novel Therpaies, Bristol
30-2
AusBio, Melbourne, Australia (Welsh Government Mission)
December 11
MediWales UK Medtech conference and Annual Awards Dinner
13
Genesis Conference, London
January 18-19
IBHI Indo-UK Diabetes Summit, India
28-31
Arab Health, Dubai (Welsh Government Mission)
February
MediWales/HealthTech and Medicines KTN Seminar: clinical unmet needs (tbc)
March
BioWales Conference 2013, Cardiff, Wales (tbc)
April 16-17
In4matics healthcare and informatics expo, Birmingham
22-25
BIO International Convention, Chigago, USA
May 1- 2
Medtec UK Conference, London
3
Wellcome Trust Health Innovation Challenge Fund (round 8), funding deadline
13-15
eHealth Week Conference, Dublin, Ireland
13-16
ACHEMASIA 2013, International Mission, Beijing, Asia
21-24
Hospitalar 2013, International Mission, Sao Paulo, Brazil
29-30
BioDundee International Conference, Scotland
If you would like us to promote your event on our website, please get in touch: debbie.laubach@mediwales.com 22 17
Members’ Directory 2012
ACADEMIC DEPARTMENTS
Aberystwyth University - Commercialisation & Consultancy Service Visualisation Centre Aberystwyth University Aberystwyth SY23 3BF +44 (0)1970622385 www.aber.ac.uk/en/ccs ccservices@aber.ac.uk
Aberystwyth University offers a breadth of research activity. Access to University technology and expertise is provided by Commercialisation and Consultancy Services (CCS) who offer an interface to businesses and other external organisations with an interest in research and development opportunities, consultancy, licensing and technology transfer in plant breeding, animal science & nutrition, pharmaceuticals & agrochemicals, microbiology, parasitology, food quality, diagnostic & analytical sciences, environmental management, proteomics, genomics & metabolomics, visualisation and healthcare imaging. Activity includes consultancy, contract research, continued professional development and training, and collaborative research.
ASTUTE ASTUTE - Cardiff Project Office Cardiff School of Engineering Cardiff University, Queen’s Buildings, The Parade Cardiff CF24 3AA +44 (0)2920 874173 www.astutewales.com marshjl@Cardiff.ac.uk Twitter : @AstuteWales
ASTUTE is a £27m five year project part funded by the European Regional Development Fund through the Welsh Government, which aims to boost the competitiveness of the Welsh economy through supporting manufacturers and their supply chains within the Welsh Convergence Area. The project provides Welsh industry with ready access to a unique combination of technical and business expertise and specialist facilities available across eight Welsh universities, providing assistance with key industry challenges to facilitate industrial growth and long term sustainability. ASTUTE can assist your business by providing specialist advice and technical assistance through collaborative R&D projects in adopting new technologies, or improving your business processes. ASTUTE’s expertise of direct relevance to bioscience businesses includes: l Advanced Technologies: Molecular Biology, Process Chemistry, Micromanufacturing, Micro/Nano-metrology, Microcontrollers, Master/Toolmaking, Prototyping & Replication l Design & Innovation: Digital Design & Manufacturing, Product & Process Design l Operations Management: Clean Room Manufacturing, Lean & Sustainable Manufacturing, Supply Chain Logistics.
Bangor University - Advanced Medical Imaging and Visualisation Unit c/o Bangor University Dean Street, Bangor Gwynedd LL57 1UT +44 (0)1248 388244 www.medical-imaging.org.uk medvis-info@bangor.ac.uk
The Advanced Medical Imaging and Visualization Unit was established in 2011 and is one of three Biomedical Research Units funded by the Welsh Government’s National Institute for Social Care and Health Research (NISCHR). It is a partnership between the Research Institute of Visual Computing (RIVIC), the NHS in Wales, and Aberystwyth, Bangor, Cardiff and Swansea Universities. The Unit employs a team of eight research officers to work on projects where imaging and visualization technologies can provide added value to medical applications.
Bangor University - Research and Innovation Office (RIO) The Management Centre College Road Bangor, Gwynedd LL57 2DG +44 (0) 1248 38 8490 fos604@bangor.ac.uk www.bangor.ac.uk
The Research and Innovation Office (RIO) supports two key components of the University’s mission; delivering its aspiration to be a research led institution with an international reputation and contributing to the economic well being of Wales and the wider community. The Research and Innovation Office supports the delivery of the University’s Research, Knowledge Exchange and Innovation activities and provides a central contact point for businesses and other external organisations wishing to access expertise and services at Bangor.
Bangor University - School of Chemistry Deiniol Road Bangor Gwynedd LL57 2UW +44 (0)1248382383 www.chemistry.bangor.ac.uk h.tai@bangor.ac.uk
Research in the School of Chemistry at Bangor University has a reputation for excellence and covers a wide range of multidisciplinary areas including nanomaterials, sensors for drugs and explosives, molecular electronics, biological chemistry, polymer chemistry, heterocyclic and carbohydrate chemistry and other synthetic chemistry. A significant proportion of our current research is at the life science interface. For example, we have been developing therapeutic biomolecules and biomacromolecules as intrinsic drugs and/or as carriers/devices for drug delivery and tissue engineering. These include the development of synthetic mycolic acids as potential therapeutic agents in the treatment of asthma and TB, the development of carbohydrate based anti-adhesives as antibiotic-alternatives, and the development of smart photocrosslinkable copolymers as injectable hydrogel materials for drug delivery and wound healing. In addition, our experimental and computational modelling studies on biological interactions and reactions are aimed at deepening the understanding of the underpinning mechanisms on a molecular level, which eventually allows a more rational design and development of pharmaceuticals. We also work on the development of synthetic approaches towards marine natural products with extensive biological activity including potential anti-cancer and anti-viral applications.
18
Annual Review & Directory 2012
Cardiff Metropolitan University - School of Health Sciences Cardiff School of Health Sciences Cardiff Metropolitan University Western Avenue Llandaff Cardiff CF5 2YB +44 (0)29 2041 6858 / +44 (0)7585 910274 I31 abadawy@cardiffmet.ac.uk
Two IP-protected healthcare technologies benefiting millions of patients worldwide and accrueing huge financial returns to investors are ready for rapid clinical development. The first (EU and USA patented) is a unique and multifaceted alcoholism treatment based on the amino acid tryptophan in conjunction with benserazide: a drug used in Parkinson’s disease. It is the most promising combination therapy yet, as it can address all aspects of alcohol dependence. Proof of concept in humans and a pilot clinical trial in alcoholic patients should lead to marketing. The second technology is a nutritional (protein) therapy of manic and psychotic disorders that can enhance the quality of life of sufferers by decreasing symptoms and lessening the need for antipsychotic drugs thereby minimising their side effects. Proofs of concept for protein-based formulations and their efficacy in manic illness should pave the way for clinical trials and marketing by a health nutritional company.
Cardiff University - CITER Cardiff Institute of Tissue Engineering and Repair 51 Park Place Cardiff University Cardiff CF10 3AT +44 (0)2920870129 www.cardiff.ac.uk/citer citer@cardiff.ac.uk
CITER brings together life sciences and clinical expertise from Cardiff University to advance technological developments in the field of tissue engineering and repair, regeneration and rehabilitation and ultimately to improve patient care and quality of life. CITER’s three strands of activity are: interdisciplinary translational research encompassing the biomechanical, regulatory, ethical, physiologic and health service aspects of tissue engineering and repair; the provision and commercialisation of clinical service technologies; and education, training and knowledge dissemination – including an MSc in Tissue Engineering, an interdisciplinary postgraduate taught scheme which may be of interest to representatives in the healthcare sector. CITER’s range of services are potentially attractive to the NHS and pharmaceutical, biotechnology, engineering, devices and biomaterial companies.
Cardiff University - Innovation and Engagement Innovation & Engagement office Cardiff University School of Medicine UHW Main Building, Heath Park Cardiff CF14 4XN +44 (0)7595091820 hatchs@cf.ac.uk
The Innovation & Engagement Team (I&E) within the School of Medicine supports and enhances the traditional academic domains of learning, teaching and research. The activity is broad ranging and impacts positively on the School and those who we interact with. In 2009, the School implemented an I&E strategy with the following three aims: l To be recognised as a Centre of Excellence for collaboration, knowledge transfer and translational innovations l To maximise the opportunities arising from internationally acclaimed academic expertise to inform public policy and
services across the health and social sector locally and globally l To build a repository of evidence based research, information and advice accessible to national international health
service providers and the wider public. Cardiff University - Research & Commercial Division (RACD) 30-36 Newport Road Cardiff CF24 0DE +44 (0)2920874837 www.cf.ac.uk/for/business business@cardiff.ac.uk
Cardiff University has an ‘Open for Business’ policy which aims to bring academia and business together through collaborations ranging from a few hours of consultancy or contract research to multi-million pound consortium grants involving numerous industrial and academic partners. The Research and Commercial Division (RACD) is the business facing arm of the University’s central administration, and supports business by acting as a single point for initial contact and intermediary to connect industry with those academics having the knowledge and expertise to help with their needs. The Business Development Team facilitates first meetings, the development of collaborative projects, helps gain funding, and supports projects to completion. Here’s some of what we can offer: l Innovation Network l Consultancy and Research l Knowledge Transfer Partnerships l Professional Development l Student and Graduate Recruitment l Student Resources
19
Cardiff University - Wales Research and Diagnostic PETIC Room 694 Ground Floor ‘C’ Block Cardiff University Heath Park Cardiff CF14 4XN +44 (0)2920743070 www.medicine.cf.ac.uklen/petic petic@cardiff.ac.uk
PETIC is a cyclotron-based production facility providing radiopharmaceuticals for both diagnostics and research utilising both clinical and pre-clinical PETCT scanners. PETIC provides research opportunities across the Schools of Medicine, Bioscience, Chemistry, Pharmacy, Psychology and Optometry, in addition to All Wales Research Networks. The provision of the pre-clinical PET facility will be particularly attractive to the pharmaceutical industry.
PDR (National Centre for Product Design and Development) 200 Western Avenue Cardiff CF5 2YB +44 (0)2920416725 www.pdronline.co.uk jwevans@pdronline.co.uk
PDR is a world renowned design and innovation consultancy and research centre. Our work encompasses the full range of new product development support from original research and human factors through to design, prototyping, trial and New Product Introduction (NPI). PDR has significant and proven experience in medical device development in all classifications from simple disability devices and medical furniture through to complex diagnostic tools and drug delivery systems. Device development at PDR is undertaken through a proven design methodology that employs the latest design and manufacturing analysis tools and technologies to produce robust, compliant and commercially successful solutions. A deep understanding of the user and clinical needs is key and acts as the foundation to a reliable and proven product development and risk reduction process. l Usability and human factors l Specification and feasibility analysis l Conceptual design and visualisation l Mechanical engineering and detail design for manufacture l Broad manufacturing discipline experience from low to high volume and UK to offshore l Regulatory compliance support and technical file construction l Design, process and user FMEA’s l In house FEA (including non linear dynamic analysis) l In house high fidelity rapid prototyping l In house mouldflow and tooling support l In house low volume rapid manufacturing technology
Severnside Alliance for Translational Research (SARTRE) Room 2TB2.23A, 2nd Floor University of Wales Hospital Heath Park Cardiff CF14 4XN Bristol Office +44 (0)1173312046, Cardiff Office +44 (0)2920 744190 www.sartre.ac.uk l.sundstrom@bristol.ac.uk / squirecm@cardiff.ac.uk
20
The Severnside Alliance for Translational Research (SARTRE) is a partnership created between the Universities of Cardiff and Bristol to combine their efforts in translational research and to provide a focal point for interactions with the BioPharmaceutical industry. SARTRE was established in 2009 to accelerate the translation of research from Bristol and Cardiff Universities and, supported by the MRC and the Welsh Government, has provided a hub to support translational activities, networking and collaboration. The award of the MRC DPFS devolved portfolio allowed SARTRE to build and actively manage a portfolio of translational projects. Recently we have established the BioE programme funded by EPSRC and the Wellcome Trust to connect physical and life sciences and apply new technologies to address clinical challenges. We work closely with university technology transfer organisations, NHS trusts and external stakeholder organisations to provide a seamless pathway to accelerate delivery of projects to agreed milestones and timelines.
Annual Review & Directory 2012
Swansea University - Advanced Professional Training Wallace Building, College of Science Swansea University Singleton Park Swansea SA2 8PP +44 (0)1792295379 www.swansea.ac.uk/aptbioscience info@APTbioscience.swansea.ac.uk Twitter: @APTBioscience
Advanced Professional Training (APT) in bioscience is a new range of Swansea University accredited training courses designed to meet the needs of individuals and businesses in the Welsh bioscience sector. Part of the ESF funded WorkBased Learning Programme, courses aim to equip professional learners with practical skills and specialist knowledge to enhance their existing laboratory or field skills. Courses are flexible and allow learners to select a number of complementary modules to tailor their learning to their professional roles. Our courses are also ideal for those seeking high quality Continued Professional Development. Contact us to find out more about our laboratory-based training, whether your are interested in basic skills or advanced techniques for postgraduates. Training may be free to eligible companies within the Welsh Convergence Region.
Swansea University - Centre for NanoHealth Swansea University Singleton Park Swansea SA2 8PP +44 (0)1792602983 nanohealth@swansea.ac.uk
The Centre for NanoHealth (CNH) is a unique open access interdisciplinary research centre based on the application of Nanotechnology leading innovations in Healthcare. This is a joint initiative between the Colleges of Medicine, Engineering & Science at Swansea University and the Abertawe Bro Morgannwg University NHS Health Board. It offers exciting opportunities to work at the interface between engineering biomedical science and clinical delivery, through access to a wide range of academic and clinical expertise and partnerships, as well as state-of-the-art nanotechnology and biomedical R&D facilities. The CNH seeks collaborations with industry in the healthcare, engineering, and biotechnology sectors requiring access to the state of the art facilities in the Centre for NanoHealth or academic partners in the healthcare arena. For more details on the extensive equipment available please visit the facilities and equipment page on our website: www.swan.ac.uk/engineering/nanohealth/facilities/equipment The £21.6 million CNH project is funded through the European Regional Development Fund via the Welsh Government, Swansea University, Welsh Government Department for Health, ABM Health Board, and the private sector.
Swansea University - Complex Fluids School of Engineering Singleton Park Swansea SA2 8PP +44 (0)1792295862 www.swansea.ac.uk/chemeng/ centre/home.htm g.m.coss@swansea.ac.uk
Internationally acknowledged research excellence in the areas of process, chemical and biochemical engineering underpins the Centre’s engagement with industry in Wales and globally, in areas such bio-processing, foods processing, lubrication and filtration. We have extensive expertise in colloids, rheometry and advanced surface characterisation techniques. Complementing our existing commercial activities, the Centre is now targeting engagement with the biomedical industrial sector. The Centre has a unique shared laboratory within Morriston Hospital and is developing new rheometrical approaches to monitoring and understanding blood coagulation, blood clot viscoelasticity and blood clot structure. Other biomedically relevant areas of research include a novel polymer fabrication process that constructs porous polymer scaffolds and a collaborative project with a Welsh SME pioneering the development of an artificial lung.
Swansea University - eHealth Industries Innovation (ehi2) Centre Second Floor Institute of Life Science (Building 2) Swansea University Singleton Park Swansea SA2 8PP +44 (0)1792606838 www.ehi2.swansea.ac.uk e.l.hughes@swansea.ac.uk
The eHealth Industries Innovation (ehi²) Centre is a business-facing centre for the ehealth industries, supporting the development of the ehealth sector in Wales. ehi² works with companies in creating new, innovative ehealth products and services with global market potential. It provides businesses with opportunities to test, adapt, improve and evaluate ehealth products and services in a safe and reliable environment to maximise their competitive advantage. It advises and assists companies and where needed, facilitates access to clinicians, academic experts, NHS organisations, and national NHS IT and ICT programmes. It works with the NHS and other health systems to identify needs for new products and services.
21
Swansea University – Institute of Life Science Singleton Park Swansea SA2 8PP +44 (0)1792602362 www.swan.ac.uk/ils/Home s.y.newman@swansea.ac.uk
The Institute of Life Science (ILS) is the £52m research institute of Swansea University’s School of Medicine, made possible through a unique collaboration between IBM, the Welsh Government and Swansea University. It is housed in a purpose-built facility on the university’s campus, adjacent to Abertawe Bro Morgannwg University NHS Trust’s Singleton Hospital, with state-of-the-art laboratories, a business development suite and IBM supercomputer Blue C. The ILS houses over 200 specialists, including professor-led research groups, technology transfer experts and dedicated business support, actively seeking research collaboration and commercial engagement.
Swansea University - School of Medicine Grove Building Singleton Park Swansea SA2 8PP +44 (0)1792513404 www.swan.ac.uk/medicine d.v.ford@swan.ac.uk
Swansea’s School of Medicine is a dynamic environment dedicated to finding new solutions to old problems in medicine. The School’s research interests include medical genetics, cancer studies, medical epidemiology, health services research, clinical trials, health informatics, reproductive biology, neurological and developmental medicine, molecular medicine & diagnostics, medical microbiology, maxillofacial research, cytochromes P450, bioinformatics, public health, and population science. The EPSRC National Mass Spectrometry Centre is now incorporated within the School and in collaboration with IBM, the School has a ‘Blue C’ supercomputer facility for use in medical research. The Centre for NanoHealth (a £21.6 million project announced in February 2009 and supported by The Wales European Funding Office) is a collaboration with the School of Engineering at Swansea that will deliver next generation sensors and devices for the benefit of health. It aims to assist businesses by providing access to its facilities and expertise.
The Open University in Wales 18 Custom House Street Cardiff CF10 1AP +44 (0)2920471019 www.open.ac.uk/wales wales@open.ac.uk
Start something amazing today with a higher education and distance learning from the Open University. Whether you want to improve your job prospects or even find a new career, now’s the time to change your life with The Open University. Flexible learning that fits your lifestyle and budget. Many people can’t afford to stop everything to get the qualification they want. With us, you don’t have to. We help people achieve extraordinary things, with affordable qualifications delivered in a way that lets you study flexibly in and around your family and work commitments. With The Open University, learning is: l
Great value: our tuition fees don’t just cover a high quality education – they also include study materials and all the support you need to succeed
l
Affordable: depending on where you live, there are government-backed schemes to help with the cost of study and you can spread the cost with our OU Student Budget Account – find out more about affordable learning
l
World-leading: our leading edge teaching is borne out of extensive academic research, which has helped build our reputation as one of the world’s finest universities – see why we could be the best university for you
University of Glamorgan Commercial Services (UGCS) University of Glamorgan Pontypridd CF37 1DL UK +44 (0)1443482482 www.glam.ac.uk/business lobrown@glam.ac.uk Twitter: @uniglam_ugcs
22
The University of Glamorgan has a range of specialist research and commercial centres delivering services across a wide range of sectors including health, sport and science. Collaboration with external organisations is common and we have established units of national and international reputation in learning disabilities, genetics education, and health economics. Other strengths include electronic product engineering, computational biology, imaging and bio-mechanical engineering. The Commercial Services team can help you find the expertise you need to partner on innovative R&D projects or provide access to student and staff skills and facilities to address your needs. Please contact us to find out more about funding and ways that we engage with businesses.
Annual Review & Directory 2012
CONTRACT RESEARCH AND TESTING Abertawe Bro Morgannwg University (ABMU) Health Board R&D Department Morriston Hospital Swansea SA6 6NL +44 (0)1792 704056 abm.rd@wales.nhs.uk
Abertawe Bro Morgannwg Health Board provides primary and secondary healthcare services mainly for the 600,000 residents of Bridgend, Neath Port Talbot and Swansea. The Health Board has four acute hospitals providing a range of services: Singleton and Morriston Hospitals in Swansea, Neath Port Talbot Hospital in Port Talbot and the Princess of Wales Hospital in Bridgend, and is responsible for providing a number of specialist regional services including cardiac, burns and plastic surgery, and neonatal. Forensic mental health services are provided for the whole of South Wales, while learning disability services are provided from Swansea to Cardiff. A range of community based services are also delivered in patients’ homes, via community hospitals, health centres and clinics. The Health Board contracts independent practitioners in respect of primary care services, which are delivered by GPs, opticians, pharmacists and dentists. The University Health Board is committed to R&D and is a partner of Swansea University’s ILS and ILS2 developments. We have dedicated clinical trial teams and facilities, enabling collaboration with academic and business partners on research programmes across all clinical specialities.
Aneurin Bevan Health Board - Intellectual Property Group Intellectual Property Group The R&D Dept The Friars Friars Road Newport NP20 4EZ +44 (0)1633656353 abb_r&d@wales.nhs.uk
The Aneurin Bevan Health Board wishes to encourage and enable staff to participate in the generation and exploitation of intellectual property as an integral part of its commitment to delivering the best possible standard of patient care. It is the responsibility of the IP Group to manage and protect IP for the Health Board. The Group comprises Dr Chris Edwards, Consultant Medical Physicist (Chair), Prof Sue Bale, Assistant Nurse Director, Dr Tan Mian, Consultant Anaesthetist, and Ms Rosz Howell, R&D Manager. In order to encourage innovation within the Health Board, our IP Policy offers a generous scheme for financing IP protection and sharing royalty or other income with the inventor.
Bristol Urological Institute Southmead Hospital Bristol BS10 5NB +44 (0)1173235690 www.bui.ac.uk info@bui.ac.uk
The Bristol Urological Institute, based at Southmead Hospital, offers in vitro testing and clinical evaluation for innovative products for urological conditions. We have a team of medical, nursing, scientific and engineering experts who can advise on ideas from concept through to market adoption. Our services include the use of specialised microbiological and biological models for pre-clinical testing and the design and delivery of clinical studies for CE marking or post market evaluation. We can be engaged on a fee-for-service basis or as a collaborative partner. As the latter we can assist in obtaining funds for device development and testing.
Cardiff University - Anaesthesia Innovation Heath Park Cardiff CF14 4XN +44 (0)2920744852 walesanaesthesia.wordpress.com ai@cardiff.ac.uk
Anaesthesia Innovation is a focus group comprising senior academics and consultant anaesthetists from the joint Cardiff University and Cardiff and Vale University Health Board departmental section Anaesthetics, Intensive Care and Pain Medicine. We have extensive expertise in evaluating existing medical devices used in anaesthesia and respiratory and intensive care using laboratory-based tests, user assessments and clinical trials. We have formed collaborations with the NHS and industry to develop innovative solutions to particular clinical problems, successfully attracting government grants. We can provide training and educational events incorporating a broad range of simulation scenarios. We also offer help and advice to industry during the development of novel products.
Cardiff University - Wound Healing Research Unit (WHRU) School of Medicine Upper Ground Floor Room 18 Heath Park Cardiff CF14 4XN +44 (0)2920748293 www.whru.co.uk admin@whru.co.uk
WHRU has three core activities: specialist clinical services, research, and education and training. The research work completed at the unit includes conducting clinical trials to ICHGCP standards; biological research (with a particular emphasis on microbiology and material science); physical measurement (the interface of medicine and engineering/electronics); and health services research (including HRQoL and health economics). WHRU also offers an MSc in Wound Healing and Tissue Repair as well as a range of short courses. The unit collaborates with a number of other departments within Cardiff University. The target markets include health professionals working with non-healing acute or chronic wounds and healthcare companies involved in specialist wound care.
23
Cardiff and Vale University Health Board - Medical Physics and Clinical Engineering University Hospital of Wales Heath Park Cardiff CF14 4XW +44 (0)2920742014 www.wales.nhs.uk/sitesplus/864 john.maisey@wales.nhs.uk
Our clinical medical physics services include medical imaging, vascular (Doppler) ultrasound, nuclear medicine, bone densitometry and body composition determination. We have a dual-head gamma camera system for planar radionuclide imaging and single photon emission tomography; this incorporates an x-ray CT scanner. Other major items of equipment and facilities include a radiopharmacy (for the production of sterile radioactive products), dual-energy x-ray absorptiometers, duplex ultrasound scanners, a niche magnetic resonance imager, a whole body gamma radiation counter and a range of other radiation detectors. We have expertise in protection against both ionising and non-ionising radiation. In clinical engineering we provide a wide range of equipment management services covering the life-cycle of medical and related equipment. Our mechanical engineering section designs, develops and produces medical devices to take forward collaborative research ideas in a variety of medical specialties. We would welcome opportunities for further research and development collaborations in the above areas.
Cedar Evaluation Centre Cardiff Medicentre Heath Park Cardiff CF14 4UJ +44 (0)2920682120 www.cedar.wales.nhs.uk uhw.cedar@wales.nhs.uk
Cedar is a medical intervention evaluation centre, able to support decision making in healthcare by providing information and recommendations on emerging health technologies, medical devices, diagnostic testing, healthcare interventions and NHS service configuration. Established in 1977, Cedar has a long and successful history of evaluation for a succession of UK government bodies. Cedar is a consortium between Cardiff and Vale University Health Board (UHB) and Cardiff University and has a contract with the National Institute for Health and Clinical Excellence (NICE) working in the Medical Technologies Evaluation Programme (MTEP). In addition to its work for NICE, Cedar is able to undertake bespoke work for public and commercial organisations and seeks to broaden its portfolio of projects through further collaboration. Cedar works to a quality system that is accredited to BS EN ISO 9001:2008 and uses PRINCE2 to manage its projects. Cedar has expertise and experience in: l Systematic evidence review – literature searching and critical appraisal l Project management l Stakeholder engagement l User assessments l Standards testing for medical/consumer health devices l Research facilitation l Health economics l Report writing
NHSBT - Clinical Biotechnology Centre (CBC) Langford House Lower Langford Bristol BS40 5DU +44 (0) 117 928 9388 www.ibgrl.blood.co.uk/CBC.htm enquiries.cbc@nbs.nhs.uk
CBC was set up to provide a small scale GMP facility producing biopharmaceuticals for Phase I/II clinical trials on behalf of NHS and academic soponsors. We hold a Manufacturer’s Authorisation (Investigational Medicinal Products) granted by the MHRA in 2004 and in 2007 this was extended to cover the GMP importation from suppliers outside the EU. We have been producing both recombinant proteins and DNA plasmids (as naked vaccines and as precursors for viral vector production) since 2000 and with over 30 DNA plasmids and five recombinant proteins currently in trials we have a proven track record of success. We provide translational research services to our sponsors as they progress from pre-clinical to clinical trials and can provide advice on the preparation of the CTA. As part of NHSBT we are a not-for-profit organisation and our academic and NHS sponsors are charged at cost for our services.
Surgical Materials Testing Laboratory Princess of Wales Hospital Coity Road Bridgend CF31 1RQ +44 (0)1656752820 www.smtl.co.uk info@smtl.co.uk Twitter: @SMTLab
The Surgical Materials Testing Laboratory, part of the Welsh NHS, provides a range of testing and technical services to the NHS and the medical device industry worldwide, including but not limited to: l l l l l l l l
Physical and biological testing of disposable medical devices to national and international standards Dressings testing (fluid handling and affinity, conformability, to BP and BS requirements) and bandage testing to BS 7505 Biological testing (cytotoxicity testing to ISO 10993-5, protein testing to EN455-3) Hosiery testing to BS 6612, 7672 and 7563 and glove testing to EN 455 Microbiological testing, including bioburden, endotoxin, barrier and antimicrobial testing (e.g. silver dressings) Environmental monitoring of cleanrooms (to ISO 14644-1 and GMP) Surgical instrument evaluations (single use and reusable) Test method development, R&D and incident investigation
SMTL is UKAS accredited to ISO 17025 for test laboratories.
24
Annual Review & Directory 2012
CHARITIES ASH Wales ASH Wales is the only voluntary organisation in Wales with the sole task of tackling the ill health caused by tobacco use. We have been working in Wales since 1976, and since 2007 as a separately devolved charity. Our activity is increasingly with children and young people as Wales has some of the highest numbers of young smokers. 8 Museum Place Cardiff CF10 3BG +44 (0)2920641101 www.ashwales.org.uk john@ashwales.org.uk Cerebra Cerebra is a charity helping brain injured children. It set up its Innovation Centre in conjunction with the Swansea Metropolitan University to provide a research, design and manufacturing service to design and build specialist equipment and adaptations that are not already available to buy. The Innovation Centre consists of a small team of designers who are able to respond to requests to build bespoke and small production runs of products to help children with neurological conditions. 2nd Floor Offices Lyric Building, King Street Caramarthen SA31 1BD +44 (0)1792483688 www.cerebra.org.uk rossh@cerebra.org.uk
We have expertise in the areas of electronics, design and engineering. We also work with a range of industry partners and other charities in the development of products.
Tenovus
Gleider House Ty Glas Road Cardiff CF14 5BD +44 (0)2920768850 www.tenovus.org.uk post@tenovus.org.uk
At Tenovus our aims are simple: to help prevent, treat and find a cure for cancer. In doing that we offer support, advice and treatment for cancer patients, information on cancer prevention and funding for research to improve the outcomes for people with cancer. We do this where it is needed most – right at the heart of the community. Our vision: Tenovus wants a future where: l Fewer people get cancer l Everyone with cancer will have equal access to excellent treatment and support Our mission: We will work in partnership to deliver innovative research-led cancer prevention, treatment and support in the community to people with the greatest need, initially in Wales. Our aims: To deliver this vision, we have agreed a set of 4 strategic aims for the organisation for the next five years. They are: Aim 1 To provide treatment to cancer patients closer to home Aim 2 To improve equity of access to cancer services Aim 3 To deliver unique support services to cancer patients and their families Aim 4 To conduct and fund research to improve cancer outcomes and experience
Cancer Research Wales At Cancer Research Wales our overriding aim is to reduce the impact of cancer on the people of Wales through supporting world class cancer research and education. We are proud to guarantee that all money raised is spent in Wales. Velindre Hospital, Whitchurch, Cardiff, CF14 2TL 029 2031 6976 www.cancerresearchwales.co.uk @cancer_wales
We sponsor pioneering research projects carried out by internationally renowned scientists and PhD students’ at universities and hospitals across the Principality. We also fund Wales’ only specialist cancer library. The Cancer Research Wales research portfolio includes a range of projects that focus on many site specific cancers, these include amongst others, cancers of the prostate, colon, cervix, kidney, breast, head and neck and blood (leukaemia). We have always been keen to promote and encourage the rapid transition of science from the laboratory to the bedside. We are only able to fund such pioneering cancer research projects because of the wonderful support which we receive from the public.
25
INDUSTRY 3M The Science Park Technology Drive Bridgend CF31 3NA +44 (0)1656 641403 http://solutions.3m.co.uk/wps/ portal/3M/en_GB/HealthCare/Home/ cramsay@mmm.com
3M Food Safety Bridgend is part of 3M Healthcare which offers innovative products and solutions for skin & wound care, infection prevention, oral care, health information systems, drug delivery and food safety. Bridgend is the development and manufacturing site for rapid hygiene testing and microbial screening products for use by dairy, food and beverage manufacturers. The products are also used in other applications including hospital hygiene, monitoring biocide treatment of industrial waters and in biodetection systems for defence agencies. The Bridgend manufactured products are part of a wider portfolio from 3M Food Safety which includes PetrifilmTM sample ready plates for enumeration of microorganisms, TecraTM pathogen test kits and a range of sample handling and media products. 3M Healthcare is part of the 3M Company, a diversified technology company with a turnover of $23.1billion and widely recognised as one of the world’s most innovative organisations.
Abcellute Tissue Bank Cardiff MediCentre Health Park Cardiff CF14 4UJ +44 (0)2920765080 http://www.abcellutetissuebank.org/ nathan.griffiths@abcellute.com
Abcellute Tissue Bank is a Research Ethics Committee approved Human Tissue Research Bank. We have ethical approval to work with NHS clinics to utilise patient constented human tissue (resulting from the normal process of surgical intervention) for the purposes of medical (academic or commercial) research. Our target markets are any research or life science institutions that require human tissue as part of product development.
AcuitasTissue Medical Abcellute Bank is a Research Technium One Kings Road Swansea Waterfront Swansea SA1 8PH +44 (0)1792 485705 www.acuitasmedical.com petaylor@acuitasmedical.com / lharry-thomas@acuitasmedical.com
Swansea based Acuitas Medical is in the final development (pre-market approval) stage of a proprietary Magnetic Resonance Imaging (MRI) based technique – Fine Structural Analysis (fineSA™). This product is an add-on software tool that provides information on anatomical structures relevant to a variety of diseases, including early stage liver and lung fibrosis, brain pathologies such as MCI and Alzheimer’s. Extensive human and animal studies have demonstrated that fineSA will identify non-invasively the earliest changes in pathologies, creating an extremely fast early-stage biomarker. The pathology specific diagnostic imaging tools can be implemented on any MRI platform. fineSA allows for an entirely new paradigm in diagnostic imaging, providing information on disease and treatment effectiveness at an anatomical scale, superior to any existing in-vivo method. Acuitas Medical’s virtual biopsy software tools acquire data in as little as 15 seconds and can be readily installed on any MRI imaging system, without modifications or additional hardware.
Alere Connected Health Saint Line House Mount Stuart Square Cardiff CF10 5LR +44 (0)7876 712021 www.hometelehealthltd.co.uk / www.alere.co.uk david.muxworthy@alere.com
Alere Connected Health (ACH) formerly Home Telehealth Ltd (now part of the Alere group) is a telehealth and telemedicine organisation specialising in the provision of clinical managed services and telemedicine technologies for remote health and social care monitoring of patients with long-term conditions. Our clinical monitoring centre provides the proactive holistic clinical telehealth service 365 days a year, 24 hours a day. ACH has won three consecutive national awards in 2008-2010 for “Innovation and Partnering with the NHS”, with over 10 years’ experience in delivering telehealth, telemedicine and technology-enabled care to NHS and local authority health and care organisations. ACH has delivered services to over 1,200 long term condition (LTC) patients in the NHS, reducing unplanned emergency admissions by 50%, with a return on investment (ROI) of 112%, this has allowed patients to remain at home whilst providing support and education to facilitate better self-management.
26
A nAnnunaul aRl eRv ei ev w & D t oc rt o y r2y 0 2 10 112 iew & i rDei cr e
Applied Enzyme Technology The Gwent Group Monmouth House Mamhilad Park Pontypool NP4 0HZ +44 (0)1495750505 www.gwent.org/aet guido@gwent.org
Applied Enzyme Technology Ltd (AET) was established in 1994 with core expertise and patents in protein stabilisation, which has resulted in the successful stabilisation of many enzymes and antibodies in a number of medical biosensor devices. AET in partnership with Gwent Electronic Materials Ltd are able to develop and manufacture biosensors for diagnostic, healthcare and point-of-care applications. Sensors being developed for clients include glucose, cholesterol, creatine, ammonia, pyruvate, organophosphates, alcohol and cardiac markers. The Gwent Group of companies are capable of manufacturing up to 500,000 sensors per annum.
Arless William Russell House The Square Lightwater Surrey GU18 5SS +44 (0) 1276855777/ +44 (0) 7932794862 crispin.kirkman@emtechna.com
Arless develops human therapeutics. The first product is for sleep disorders. The company has strong know-how in thyroid hormone mechanisms and aims to add value to IP and license on.
Axiom Manufacturing Services Technology Park Newbridge Newport NP11 5AN +44 (0)1495242130 www.axiom-ms.com/en davidd@axiom-ms.com
Located in South Wales, Axiom Manufacturing Services is a highly flexible, customer focused UK Contract Manufacturing (CEM) Company delivering to the medical sector. With many years’ experience of PCB assembly, electro-mechanical assembly, full product box-build and other value added services, Axiom delivers value throughout the supply chain helping to lower your total acquisition costs. Whilst being specialists in automated drug delivery systems, laparoscopic surgery and vital signs monitoring equipment, Axiom has the capabilities and facilities to offer a complete outsourced manufacturing solution to its medical customers. From design support to after sales, extensive test capabilities and a strong quality culture, supported by our team’s ’can do’ attitude, Axiom typifies a world of excellence in contract manufacturing.
Bilcare GCS (Europe) Waller House Elvicta Business Park Crickhowell Powys NP8 YDF +44 (0)1873812182 www.bilcaregcs.com direct-europe@bilcare.com
Bilcare Global Clinical Supplies (GCS) is a global provider of Clinical Trial Materials (CTM) services to the pharmaceutical and biotechnology industries. Bilcare GCS is a business unit of Bilcare Ltd – an innovation-led solutions provider that partners with the global pharmaceutical and healthcare industry to improve patient healthcare outcomes. Bilcare GCS has global presence in North America, Europe and Asia. With best-in-class manufacturing plants and facilities on three continents, Bilcare GCS delivers end-to-end solutions that support a drug through the entire clinical trial life cycle. Our services for solid, semi-solid, liquid, DEA (CI-V) and biotech clinical trial materials (CTM) satisfy a broad range of requirements, from preformulation research and development, manufacturing, analytical services and clinical supplies packaging and labelling, to IVRS, QP services, controlled-temperature (cold chain) CTM storage, worldwide distribution and returns and destructions accountability.
BioMonde (UK trading name of ZooBiotic) Units 2-4 Dunraven Business Park Coychurch Road Bridgend CF31 3AP +44 (0)845 230 1810 www.biomonde.com enquiries@biomonde.com
BioMonde’s UK manufacturing facility is based in Bridgend, South Wales and produces larval debridement therapy products for the treatment of sloughy and necrotic wounds. All products are produced in accordance with current European ‘Good Manufacturing Practice’ (GMP) requirements in a state-of-the-art aseptic facility. ‘Free range’ Larvae300® and BioBag® Dressings are BioMonde’s core products. BioFOAM® Dressings contain larvae that are enclosed in net pouches with spacing to protect the larvae. The BioBag® products can be left on a wound for up to four days. The ‘free range’ Larvae300® are applied directly to the wound so they can seek out areas of slough or necrotic tissue. They are contained on the wound via a sterile retention net system, which is a CE-marked medical device also produced by BioMonde.
27
Biotec Services International Biotec House Central Park Western Avenue Industrial Estate, Bridgend CF31 3RT +44 (0)1656750555 www.biotec-uk.com enquiries@biotec-uk.com Twitter: @BiotecServices
With over 15 years’ experience, Biotec has built a global reputation as a company with the commitment to quality and technical excellence required to support your clinical trials from Phase I to IV and onto commercial supply. Our purposebuilt, split-site facility supports multinational trials and the commercial launch of our clients’ products on a daily basis. Our services include: l
QP and GMP Consultancy Clinical Supplies l GMP Temperature Controlled Storage l Global Logistics l Advanced Therapeutic Medicinal Products (ATMPS) l Commercial Services l
Biotec also handles containment level I and II Genetically Modified Organisms (GMOs), Schedule II to V controlled drugs, in addition to providing storage arrangements such as customs warehousing for a range of controlled temperatures from controlled ambient (15-25°C) down to -196°C. Biotec is relied upon by clients to deliver critical studies of various sizes, on time and on budget. Trust Biotec to be your international partner in clinical trials. Calon Cardio-Technology Institute of Life Science Swansea University Swansea SA2 8PP +44 (0)1792602861 www.caloncardio.com kevin@caloncardio.com
Calon Cardio-Technology Ltd (Calon) is developing a new generation of implantable micro-pump for the treatment of heart failure. Current pumps have clinically proven that heart assist pumps are a safe and effective therapy. However, these devices have so far failed to exploit their huge market potential for two reasons: current products are too large (requiring highly invasive surgery) and they are expensive at circ $115,000 per system. Calon’s technology addresses both problems and promises to realise the vision of heart assist pumps becoming the routine method of treatment for heart failure. Calon have assembled a team of world class suppliers and collaborators to take their vision to market, such as Texas A&M, The John Radcliff Hospital Oxford, Swansea University, The Technology Strategy Board and the Welsh Government.
CellPath 80 Mochdre Enterprise Park Newtown Powys SY16 4LE +44 (0)1686611333 www.cellpath.co.uk sales@cellpath.co.uk
CellPath Ltd specialises in the manufacture and world-wide supply of products, consumables and services for the histopathology and cytology markets. The Human Tissue Authority licensed archive management solution, CellNass, offers a complete answer to healthcare providers by administering pathological material in a purpose built facility, thus releasing valuable time and space for other uses. CellPath has a state of the art injection moulding capability and manufactures many of the plastic products that are used in the modern histology and cytology laboratories. The recent acquisition of further premises in Newtown has resulted in an expansion process to manufacture more products in-house, including chemicals such as stains and fixatives. The ability to sell direct from manufacture to the end user enables cost-saving without compromise on quality and service. CellPath has a continuous improvement process built around a strong desire to maintain a high level of quality, with ISO 13485.2003 and ISO 9001.2008 accreditation. Lean techniques are implemented throughout our operations including ‘5S’ philosophy. A recent audit by the HTA declared that our CellNass archive solution is of the highest possible standard.
Chromogenex Technologies Units 1&2 Heol Rhosyn Dafen Park Llanelli SA14 8QG +44 (0)1554755444 www.chromogenex.com dgmorgan@chromogenex.com
28
Chromogenex Technologies design, manufacture, and service lasers and intense light systems for the health, cosmetic and beauty markets. Our products are: l
iLipo: a body shaping, fat reduction device without the need for pain, needles or downtime
l
Phaser EPL: intense pulse light (ipl) for hair removal, skin rejuvenation and pigmentation
l
Regenlite: a pulse dye laser for vascular, acne, skin pigmentation
l
Plus Fusion3DLift: for non-invasive skin rejuvenation, including systems for tattoo removal, pigmentation, vascular lesions, psoriasis, cellulite and vitiligo
l
The company has established direct sales operations in the UK, with a worldwide distribution network.
Annual Review & Directory 2012
ConvaTec Global Development Centre (GDC) First Avenue Deeside Industrial Park Deeside Flintshire CH5 2NU +44 (0)1244584300 www.convatecglobal.com
ConvaTec is a leading developer and marketer of innovative medical technologies with four key focus areas – ostomy care, wound therapeutics, continence and critical care, and infusion devices. Our global wound therapeutics R&D centre has been based in Deeside, North Wales since 1987, and employs 50 scientists and technical staff. ConvaTec GDC now focuses on innovation in all four areas. Scientists at the Deeside site have a worldwide reputation for excellence in published research on the pathophysiology of chronic wounds such as venous leg ulcers, wound microbiology, and technologies that underpin product innovation. ConvaTec scientists are frequently invited to participate in educational initiatives, international symposia, and industry working groups. Since ConvaTec’s acquisition of the Unomedical company in September 2008, Continence and Critical Care R&D has relocated to GDC, and focuses on innovations to serve the needs of healthcare professionals in the operating room and intensive care units.
ConvaTec - Manufacturing 20 First Avenue Deeside Industrial Estate Deeside Flintshire CH5 2NU +44 (0)1244584000 joanne.graham@convatec.com
ConvaTec’s Wales manufacturing sites are part of the GMSC network of 11 plants. The Rhymney facillity in South Wales manufactures all fibres that are sent to Deeside for textiling and packaging. The Rhymney facillity employs c 100 people and is the Chemical Processing Centre of Excellence for ConvaTec. The Deeside facillity employs c 500 people and is the Hydrofiber® Centre of Excellence for ConvaTec®. In addition to Hydrofiber® production, Deeside manufactures chronic care products to support the GMSC network. Furthermore, Deeside houses ConvaTec®’s first Visitor Experience Centre. This centre is a media space designed to interact with patients, employees and commercial partners to share knowledge and continue our drive to make a difference in people’s lives by putting our patients first.
Dentron Llys Myrddin Efailwen Clynderwen Carmarthenshire SA66 7XG +44 (0)1994419792 www.dentron.co.uk admin@dentron.co.uk
Dentron manufactures innovative electronic medical devices, including the ‘Biogun’ Electronic microbicide, which kills micro-organisms (including MRSA) on skin and in dentine. It is used by chiropodists and dentists for verrucae, athletes foot, fungal nails, ulcers, tooth decay, gum disease and periodontitis.
Direct Healthcare Services Unit 8, Withey Court, Western Industrial Estate, Lon-y-Llyn, Caerphilly CF83 1BF +44 (0)8454599831 www.directhealthcareservices.co.uk sales@direct-healthcare.org.uk
Direct Healthcare Services is a rapidly expanding company in the manufacturer, distribution and service of pressure care equipment, including high specification foam mattresses, dynamic mattresses, overlays, cushions and beds. During the last 2 years the company has trebled the size of its manufacturing facility based in Caerphilly. The company prides itself on its ability to supply standard products within 24 hours, and bespoke made-to-measure products within 5 – 10 days.
DTR Medical
17 Clarion Court Enterprise Park Swansea SA6 8RF +44 (0)1792797910 www.dtrmedical.com info@dtrmedical.com Twitter: @dtrmedical
DTR Medical is an innovative medical device and cleanroom contract manufacturer, with the ability to design, CE mark, manufacture and sterilise a wide range of healthcare products. DTR Medical’s custom-built facilities include a versatile ISO class 7 cleanroom complex, operated by a highly trained team. Experienced in the manufacture and packing of many medical devices used in ENT, vascular, neurology, orthopaedic and general surgery, DTR Medical sells and markets its own brand of sterile single-use surgical instruments. The company already manufactures a wide range of custom built products for the pharmaceutical, biotechnology and diagnostic industries. Fully equipped to handle flow wrapping, shrink wrapping and vacuum packing. The facility also has specialist expertise in handling liquid filling of medical devices and related products.
29
Ensinger Precision Engineering Wilfried Way Tonyrefail Mid Glamorgan CF39 8JQ +44 (0)1443678500 www.ensinger.co.uk precision@ensinger.co.uk
Ensinger Precision Engineering Ltd (EPE) is at the forefront of precision machining technology in engineering plastics. The Company is highly focused on application engineering and works closely with customers on a technical level assisting in developing applications, specifying materials and optomising parts for manufacture. From our factory in South Wales we offer machining (2-, 3- and 5- axis turning and milling), finishing, kitting, polishing, part marking, assembly, testing and cleaning of plastics to customer specified requirements. EPE are accredited to ISO9001:2008 and ISO13485:2003 standards in addition to holding investors in people status. EPE are part of the Ensinger worldwide group of companies. Specialties: Machining (2,3,5 axis milling & turning), Application Engineering, Finishing, Kitting, Part Marking (Laser & Machine), Ultrasonic Cleaning, Assembly, Testing.
Exopack Advanced Coatings Ash Road North Wrexham Industrial Estate Wrexham LL13 9UF +44 (0)1978660241 www.exopackadvancedcoatings.com geninf@exopack.com
Exopack Advanced Coatings produces the inspire™ range of films and foams to manufacturers in the wound care, ostomy and medical device sectors. Films, foams and adhesives can be combined in a variety of ways to create novel features or brand identity. Several composites are available as part of the standard inspire™ portfolio with an added printing facility if required. Carboncontaining films that can be modified with silver or silver chloride are also part of the inspire™ portfolio suitable for a variety of electrode applications including ECG, TNS, biosensors and cosmetic applications. Exopack Advanced Coatings also offers papers, films and specialty substrates for press supplies, electronics and optical technologies.
Frontier Medical Group Newbridge Road Industrial Estate Blackwood NP12 2YN +44 (0)1495 235800 www.frontier-group.co.uk info@frontier-group.co.uk
Frontier Medical Group manufactures and markets a range of medical products in three broad business streams: l
Sharpsafe is Europe’s leading brand of plastic sharps disposal containers
l
Repose is a range of inflatable polyurethane pressure redistribution devices for the prevention and treatment of pressure ulcers, manufactured under license from the NHS
l
Exchange is the brand under which products are made available to organisations for harm reduction purposes amongst the intravenous drug-using community
Frontier is based at two factories in Blackwood with facilities for plastic injection moulding and welding. The core market in the UK is the NHS although approximately 50% of production is exported, mostly to the EC.
GE Healthcare Cardiff Laboratories Forest Farm Rd Whitchurch Cardiff CF14 7YT +44 (0)2920526421 www.gehealthcare.com/uken paul.michael@ge.com
GE’s Maynard Centre facility develops and manufactures reagents and reagent systems to support customer research in genomics, proteomics and cell biology. These reagents are frequently designed for use on the company’s instrument platforms. Key target market sectors are the early stages of drug discovery programmes in the major pharmaceutical companies worldwide, in particular high-throughput drug screening, metabolism and distribution studies. The facility also offers a custom manufacturing service.
Haemair Unit 5, Room 403 ILS Phase 2 Singleton Park Swansea SA2 8PP +44 (0)1792602466 www.haemair.com sbrown@haemair.com
30
In the UK eight million people suffer from, and 100,000 die from, lung disease annually. The Haemair device takes carbon dioxide directly from the blood and replaces it with oxygen. It is compact, portable and suitable for conscious, active patients. Unlike conventional treatments, the device does not use the lungs. Current treatments that force damaged lungs to work harder through mechanically supported breathing can be ineffective and can result in long-term lung damage in recovering patients. The Haemair device offers more effective treatment with better long-term outcomes. A similar device treats transfusion blood. Conventionally stored transfusion blood loses its ability to transport oxygen and takes over 24 hrs in a patient before it is reactivated. For patients requiring large transfusions this relatively inert blood initially hinders the patient’s recovery and thousands of people die from blood transfusions annually. Haemair aims to make blood transfusions safer and more effective.
Annual Review & Directory 2012
Huntleigh Huntleigh, a member of the Getinge group of companies, is a leading global provider of innovative and high quality medical equipment for healthcare professionals. The Diagnostic Products Division can proudly boast world leading brands such as Sonicaid, Dopplex and Smartsigns, covering healthcare requirements in obstetrics, vascular assessment and patient monitoring.
Diagnostic Products Division Unit 35 Portmanmoor Road East Moors Cardiff CF24 5HN +44 (0)20 20485885 www.huntleigh-diagnostics.com sales@huntleigh-diagnostics.co.uk
The ISO13485 accredited site at Cardiff designs, manufactures and distributes a broad portfolio of electronic medical products thanks to its extensive R&D capability. These innovative products include market leading pocket Dopplers used for vascular assessment and fetal heart rate monitoring. The factory also manufactures a comprehensive range of fetal monitors for antenatal, labour and delivery applications, together with a range of patient, bedside and vital signs monitors. To enhance the product ranges and provide a seamless electronic data management solution, a range of clinical information systems have been developed, and are available with full technical and clinical support services.
Ig Innovations Ig Innovations Ltd offers bespoke antibody production and supply to the research, diagnostic, biotech and pharmaceutical sectors: from antigen design, peptide synthesis, conjugation, through to antibody purification, conjugation and assay development. We can deliver small volumes to the research customer through to large pools to satisfy assay lifetime requirements of in-vitro diagnostic customers. Ig Innovations offers a large catalogue of antibodies from high volume stocks, available in any format that the customer requires. Employing our wealth of experience we can work with customers to advise and consult on specific antibody requirements and assay development, in particular POC. Ig Innovations Ltd is an Alere Company.
Gernos Maesllyn Llandysul SA44 5LP +44 (0)1239858972 www.ig-innovations.co.uk chris.williams@ig-innovations.co.uk
Experienced and capable partner for grant applications for immunoassay diagnostic projects. Invacare (UK) Invacare’s UK operations were founded in 1856 and the company now employs over 200 people. Based in South Wales, it is ideally placed to provide the UK healthcare market with a range of products and services that meet the demands of both the public and private sectors.
Pencoed Technology Park Pencoed Bridgend CF35 5AQ +44 (0)1656776222 www.invacare.co.uk uk@invacare.com
Over the years, Invacare UK has selected and merged with a number of UK manufacturers and now offers a comprehensive portfolio of wheelchairs, scooters, respiratory, beds, mattress and cushion products, lifting, bathing, and walking aids. Invacare’s commitment to product design and quality has resulted in a comprehensive range of solutions for independence and mobility.
Kodit Database Evolution House Lakeside Village St Davids Park Ewloe Flintshire CH5 3XP +44 (0)8453707706 www.kodit.com info@kodit.com
Kodit designs web enabled mobile medical data collection and verification applications which increase the efficiency of dayto-day medical procedures and provide clinicians with real time information crucial to the well being of their patients. Not limited to a Hospital setting, Kodit also provides systems for care home, residential care and care in the community. All our products have been designed with the input of clinicians, nursing staff and care workers to ensure that they are both easy to use and provide demonstrable benefit to their patients/residents. .
31
MedaPhor Suite 16 Cardiff Medicentre Heath Park Cardiff CF14 4UJ +44 (0)2920756534 www.medaphor.com stuart.gall@medaphor.com
MedaPhor is the UK’s leading ultrasound education and training company, producing innovative training products for postgraduate medical professionals. MedaPhor’s range of products and services includes the new award winning ScanTrainer Transvaginal Simulator, a virtual ‘real-feel’ ultrasound training simulator, which provides curriculum-based training, independent of a clinical setting. The company also sells a range of e-learning ultrasound modules and organises regular 3-day ‘hands-on’ ultrasound courses in Cardiff for obstetrics and gynaecology. MedaPhor’s products and services are suitable for postgraduate students, gynaecologists, obstetricians, radiographers, midwives and nurses to develop critical knowledge and skills as part of their training. They are also suitable for practitioners for fulfilling their continued professional development (CPD) and for trainers, as an indispensable teaching resource for the classroom and lecture theatre. MedaPhor is committed to creating high-quality ultrasound training systems for worldwide medical healthcare.
Microsemi Phase 2, Castlegate Business Park Portskewett Caldicot Monmouthshire NP26 5YW +44 (0)1291 435342 www.zarlink.com/zarlink/hs/ AdvancedPackaging.htm martin.mchugh@microsemi.com
Microsemi’s Advanced Packaging Division delivers competitive advantage for its customers through miniaturising electronic circuits, enabling wireless connectivity and developing novel energy sources for medical devices. With a track record of success in designing and developing miniaturised electronic modules, Microsemi’s Advanced Packaging Division is at the heart of mission-critical projects in such applications as pacemakers, neurostimulators, sensors, hearing aids and patient monitoring. Technology development is underpinned through TSB and FP7 collaborations with leading research organisations and companies where Microsemi plays a leading role in management and exploitation. Current projects include energy harvesting, In/on body wireless communications and embedded components to drive the next generation of 3D miniaturisation.
Microvisk Technologies Unit 4 Ffordd Richard Davies St Asaph Business Park Denbighshire LL17 0LJ +44 (0)8459569900 www.microvisk.com denisearcher@microvisk.com
Microvisk is a medical device company based in St Asaph, North Wales. We have developed a proprietary technology which creates moving parts on the surface of silicon chips. Using this technology we are about to launch an instrument which measures blood thinning for people who take Warfarin, enabling the Warfarin dose to be optimised. In addition to the surgery and hospital, the instrument can be used by the patient at home, removing the need to travel to the surgery on a regular basis. Following clinical trials the product is due for launch in Europe in 2012. The technology has the potential for many more medical applications.
Morvus Technology Ty Myddfai Llanarthne Carmarthen SA32 8HZ +44 (0)1558667182 www.morvus.com jphillips@morvus.com
Morvus Technology is a privately-owned company engaged in the discovery, development and commercialisation of novel therapeutics and diagnostics for the oncology market. The Company was established in 2004 and has offices and laboratories near Llanarthe, South Wales. Morvus has a broad portfolio of technology which is focused on disease areas for which there is a clear, unmet medical need.
Neem Biotech Unit 1-3 Willowbrook Technical Units St Mellons Cardiff South Glamorgan CF3 OEF www.neembiotech.com markwhite@neembiotech.com
32
Neem Biotech operate low cost extraction of active compounds from plants and marine life, production, research and process development. Current products and research work includes garlic; artemisinin; azadirachtin; horseradish; aloe ferox; and other South African flora. Relevant targeted market sectors (human and animal): pharmaceuticals; neutreceuticals; OTC; animal feed additive market; crop health and pest control. We are looking to add to our current commercial relationships with companies and academic institutions, both in the UK and overseas.
Annual Review & Directory 2012
Nightingale Care Beds Unit 1, Ash Road South Wrexham Industrial Estate Wrexham LL13 9UG +44 (0)1978660810 www.nightingalebeds.co.uk info@nightingalebeds.co.uk
Nightingale Care Beds Ltd is a manufacturer and supplier of Bariatric Care Systems into the clinical sector. We have brought together a range of equipment to compliment our ProAxis Plus bariatric bed to enable the care of heavier patients with safety and dignity. We offer a 24/7 rental service with average delivery times of under four hours within the UK. This has recently been enhanced with our fixed price Bariatric Package scheme which offers all the equipment required with one call, at one price. All products are available for sale, with stock held for immediate delivery.
Norgine Tir-y-Berth New Road Hengoed CF82 8SJ +44 (0)1443812183 www.norgine.com
Norgine Ltd is the UK-based affiliate of Norgine, an independent pan-European pharmaceutical company. With UK headquarters at Harefield, Middlesex and a manufacturing site at Hengoed, Mid Glamorgan, Norgine conducts an international business. Norgine employs about 600 people in the UK and a further 400 in its affiliated companies. The company markets a broad range of prescription medicines through a network of daughter companies and distributor partnerships in the UK, Ireland, the Nordic region, the Middle and Far East, South Africa, Australia and Latin America. About 80% of sales derive from products used in the treatment of gastro-intestinal illness. Research and acquisition strategies reflect our interests in gastroenterology and hepatology.
Orthos Unit 29 Technium Springboard Llantarnam Park Cwmbran NP44 3AW +44 (0)1275376377 www.orthos.com info@orthos.com
The company is focused on developing materials and devices that provide solutions for surgeons to use in the repair of skeletal defects and in the regeneration of bone. To achieve this the company works in partnership with clinicians and academia. The Company’s products are particularly suited to newly emerging surgical techniques such as the treatment of vertebral compression fractures. The Company’s core technology is based on the synthesis of orthobiologic materials which respond physiologically when implanted in the body. The Company has products approved for sale in both Europe and the USA.
Penn Pharma Units 23-24 Tafarnaubach Industrial Estate Tredegar Gwent NP22 3AA +44 (0)1495711222 www.pennpharm.com enquiries@pennpharm.com
Penn Pharma is a leading provider of integrated pharmaceutical development, clinical trial supply and custom manufacturing services to the international healthcare industry. Our core services include formulation and analytical development; clinical trial manufacturing, labelling, packing, storage, distribution, returns and destruction; specialised contract manufacturing; CMC consultancy; and Qualified Person release services. Penn Pharma also offer High Containment Operations for the formulation and manufacture of highly potent substances for use in clinical trials, and from 2013 will be able to manufacture potent commercial products in a new state-of-the-art containment facility. Penn manufactures to GMP (Good Manufacturing Practice), is licensed by the UK MHRA (Medicines and Healthcare products Regulatory Agency), and is FDA (US Food and Drug Administration) inspected.
Promove UK 72 Geryllan Penrhyncoch Aberystwyth SY23 33HQ +44 (0)1970 820893 www.promove.uk.com enquiries@promove.uk.com
Promove UK design and manufacture manual handling slings to move an incapacitated person when a hoist is not available. Eight variants on the design are sold to the Emergency Services, disabled individuals, schools, theatres and sports venues. The company is a bronze medal winner for medical devices at Geneva International Inventions Salon, 2008.
33
Protherics UK, a BTG International group company Blaenwaun Ffostrasol Llandysul Ceredigion SA44 5JT +44 (0)1239 851 122 www.btgplc.com info@btgplc.com
BTG are an international specialist healthcare company, developing and commercialising products targeting critical care, cancer and other disorders. Our mission is to bring to market medical products that meet the needs of specialist physicians and their patients, and in doing so to build a sustainable, profitable business that delivers superior returns to our shareholders. In January 2011, we completed the acquisition of Biocompatibles International plc. This has expanded our commercial business with the addition of approved interventional oncology products, and has broadened our pipeline of internal development and partnered programmes.
Pulse Medical Technologies Swansea University Singleton Park Swansea SA2 8PP +44 (0)1792606670 www.pulsemedtech.com/ www.amethystwoundproject.com francis.cooper@pulsemedtech.com
Pulse Medical Technologies design and manufacture medical devices for pain relief and wound healing. Pulse Medical Technologies was incorporated to design and develop pain relief and wound relief products using the therapeutic and healing properties of Pulse Electro-magnetic Field Therapy (PEMF), which has been cleared by the major national international Medical Authorities to treat medical conditions such as non-union bone fractures, wound healing and pain relief. The company is based in the prestigious Institute of Life Sciences in Swansea University and has access to world class research and development facilities and personnel who are currently working on its projects. The company’s main activity currently centres on the FP7 grant funded project called AMETHYST, which stands for: Ambulatory Magneto-Enhancement of Transdermal High Yield Silver Therapy Coming from a background in producing medical devices for pain relief using PEMF and through the extensive research the company undertook into PEMF for wound healing, it became evident that there was a large unmet need to develop an innovative solution to increase the speed of healing for chronic leg ulcers. The project entails passing an electromagnetic wave through silver to increase the efficiency of wound healing. Results to date have been extremely encouraging and the project is on target to be very successful. The company has been granted a European patent to cover the concept and is in the process of securing worldwide protection.
Q Chip Oddfellows House 19 Newport Road Cardiff CF24 0AA +44 (0)2924800180 www.q-chip.com info@q-chip.com
Q Chip, a biopharmaceutical drug company, is developing Q-Sphera™ - a range of injectable sustained-release biogeneric and biotherapy products. Q-Sphera products are biocompatible microspheres containing active pharmaceutical ingredient (API), made using Q Chip’s patented encapsulation platform the MicroPlant™ device. The key advantages of the Q-Chip Sphera format are: l The microspheres are extremely monodispersed with a high encapsulation efficiency of API l It is API neutral l Fast and inexpensive drug development l Low cost manufacturing for biogenerics. Q Chip’s lead biogenerics products are Q-Leuprolide (primary indication for prostate cancer) and Q-Octreotide (primary indication for acromegaly). Both products are available for out licensing. Q-Sphera is also highly enabling for the encapsulation of fragile proteins for bio-therapeutic use.
Rogue Resolutions Rogue Resolutions provides integrated equipment solutions and services within the neuromodulation, neuronavigation, brain imaging and neurofeedback sectors. In order to achieve this we have developed an extensive portfolio of products that are engineered to function in a seamless manner, maximising the potential of these complimentary devices and offering the customer a fully integrated solution to accomplish their research needs. Sophia House 28 Cathedral Road Cardiff CF11 9LJ +44 (0)2920660198 www.rogue-resolutions.com info@rogue-resolutions.com Twitter: @rogue_resol
34
Annual Review & Directory 2012
Simbec Research Merthyr Tydfil Industrial Park Cardiff Road Merthyr Tydfil CF48 4DR +44 (0)1443694309 www.simbec.co.uk alan.woodward@simbec.co.uk
Simbec Research, one of Europe’s longest established CROs, provides clinical and bioanalytical contract services to the international pharmaceutical and biotechnology sectors. Simbec conducts early clinical trials ranging from first in human Phase I studies in healthy subjects through to Phase IIa proof of concept trials in patients, with full bioanalytical back up and related services, and particular expertise in studies involving ophthalmology, dermatology and gamma scintigraphy imaging. Our Altasciences sister company, Algorithme Pharma, has Phase I and Bioequivalence facilities in Montreal (Canada) and a global capacity to conduct multi-regional and multi-ethnic studies.
Sony UK Technology Centre Pencoed Technology Park Bridgend CF35 5HZ +44 (0)1656860666 www.sonypencoed.co.uk UKTEC_Biz_enquiries@eu.sony.com
We are the only manufacturer of Professional and Broadcast Camera Systems for Sony Corporation with a worldwide customer base located outside of Japan. We also act as a Contract Electronics Manufacturer of professional, industrial and consumer electronic devices, offering the complete business solution to various market leading companies. Our facilities include a state-of-the-art SMT facility, Poke Yoke cell assembly, test jig design capability, award winning service and customer call centre and SCM services and DFM engineering support.
Sterilin (now Thermo Fisher Scientific) Parkway Pen-y-Fan Industrial Estate Newport NP11 3EF +44 (0)8448443737 www.sterilin.co.uk info@sterilin.co.uk
Sterilin, now Thermo Fisher Scientific, specialises in the manufacture of single-use laboratory plastics and comprises four established product brands: Sterilin Single Use Plastics; Iwaki Tissue Culture Products; Sterilin Silicone Devices; and Sterilin Packaging Products. The Sterilin brand is synonymous with quality, reliability and user safety and offers a wide range of products for the pharmaceutical, clinical, healthcare, medical devices and industrial packaging industries. All Sterilin products are manufactured at the company’s ISO 9001:2008-accredited plant in South Wales (UK), where a commitment to the improvement in manufacturing processes and product development, and clean room and microbiological research facilities, ensures that every item is made to the highest possible quality. Our worldwide distribution network ensures access to the extensive Sterilin portfolio from all areas of the globe.
Symlconnect Room 503, ILS2 Singleton Park Swansea University Swansea SA2 8PP +44 (0)1792606524 www.symlconnect.com info@symlconnect.com
SymlConnect is offering an innovative multi-directional software platform, designed specifically for information-exchange to address concerns of interoperability within the healthcare sector. The standards-based modular and customised solution provides clinicians remote, but confidential, access to existing systems, allowing sharing of essential information on demand. Disparate systems, multiple paper based forms and physical methods of communication are all integrated into one smart mobile device (platform independent), to provide significant time and cost savings whilst increasing clinical efficiency and patients experiences. The ability of secured sharing anywhere anytime, without having to discard the existing systems, provides the interoperability. Unique Selling Points: l
Information-exchange between systems without distorting individual legitimacy
l
Not constrained by legacy systems or future advancements
l
Allow parallel access to patient information
l
Adaptable and scalable solution
l
Allow incremental expansion
Our aim is to partner with providers, health authorities and academics, to develop smart bespoke integrated applications to simply connect people, systems and organisations.
35
Synergy Health Laboratory Services Gavenny Court Brecon Road Abergavenny NP7 7RX +44 (0)1873856688 www.synergyhealthplc.com labservices.info@synergyhealthplc.com
Synergy Health Laboratory Services Ltd (SHLS, formerly JMJ Laboratories Ltd and Grendonstar Ltd) was founded over twenty years ago and provides fully accredited analytical services to clients in all industry sectors. Now a division of Synergy Health plc, we specialise in workplace drug and alcohol testing and general pathology. We offer consultancy, formal training in drug awareness, drug policy implementation and the only UKAS accredited chain-of-custody collection service in the UK. SHLS’s comprehensive analytical portfolio extends to MRSA screening, virology, immunology, biochemical and microbiological environmental monitoring and substance identification.
Synidor Institute of Life Science School of Medicine Swansea University SA2 8PP +44 (0)7721856324 www.synidor.com frank@synidor.com
Specialises in patient monitoring for immobility in beds and chairs.
The Magstim Company Spring Gardens Whitland Carmarthenshire SA34 0HR +44 (0)199 424798 www.magstim.com info@magstim.com
Magstim provides the means for neuroscientists to work with the human brain in awake subjects by manufacturing and supplying state-of-the-art clinical and research instruments. Magstim and Neurosign products cover the fields of neurology, neurophysiology, psychiatry and cognitive neuroscience as well as ENT, orthopaedic and neurosurgery. Magstim maintains a strong commitment to R&D and product improvement. Collaborating with researchers in British and European major centres of expertise (as well as those in North America and Japan) ensures that Magstim remains informed about clinical and medical advances, enabling the company to develop products at the forefront of technology.
Theryte William Russell House The Square Lightwater Surrey GU18 5SS +44 (0)1276855777 www.theryte.com bill.primrose@theryte.com
Theryte is a cancer drug discovery and development company. Its technology builds on a previously undescribed mechanism of action and is intrinsically selective to cancers whilst sparing normal human cells. Development is currently at the pre-clinical stage. Theryte’s experimental data suggest that there exists a relatively small number of key proteins which co-operate to exert a novel function in cancer cells, and by so doing re-stabilise the otherwise unstable cancer cell. A recent peptidomimetic compound shows significant anti-cancer activity against a range of solid tumour types and Theryte has embarked on a program of work to achieve in vivo proof of concept. Theryte outsources the majority of its R&D activities, and has requirements for medicinal chemistry, early ADME/Tox. studies, in vivo pharmacokinetics, tolerability and xenografts. In addition, the company is looking for collaborators and partners who can carry out cancer biochemical and genetics experiments to further investigate the novel mechanism of action.
Time for Medicine Cardiff Medicentre Heath Park Cardiff South Glamorgan CF14 4UJ +44 (0)2920757744 www.timeformedicine.com enquiries@timeformedicine.com
36
The company is a spin out from the University Hospital of Wales in Cardiff (UHW). The objective of this business proposition is to develop diagnostic software to replicate the skills of the best clinical consultants and perform the role of the specialist in diagnosing patients’ conditions. The company’s web based diagnostic interface will replace the need for patients to visit specialist consultants in large hospitals, with all the attendant waiting times and costs. Additionally the company is developing mobile platforms for the remote management of many chronic conditions. The company’s products are aimed at both the private market, i.e. direct to consumers over the web, and the public market, through the NHS with the objective of significantly reducing costs while maintaining or improving service provision. The company has the backing of over 50 senior clinical consultants in Cardiff and other parts of the UK, The Cardiff and Vale University Health Board and the Welsh Government.
Annual Review & Directory 2012
Trojan Electronics Unit 10-11 Garngoch Industrial Estate Gorseinon Swansea SA4 9WG +44 (0)1792892221 www.trojan-electronics.co.uk sales@trojanelectronics.co.uk
Trojan Electronics specialise in supplying electronic sub-contract services. Whether you require a full turnkey solution or you prefer to free-issue your components, Trojan can cater for your needs. Our flexible approach means no job is too big or small, whether it is for a new product launch, internal short term capacity problem or scheduled orders, we can cater for your specific requirements. Services: l Surface mount & through hole placement l Free-issue or full procurement and full product assembly & test service l Prototype to volume production l Lead free & leaded assembly l Quick response & turnaround times and full MRP system offering full traceability – competitive prices
Ultrawave Eastgate Business Park Wentloog Avenue Cardiff CF3 2EY +44 (0)8453304236 www.ultrawave.co.uk admin@ultrawave.co.uk
Ultrawave are one of the UK’s largest manufacturers of precision ultrasonic cleaning equipment and have been supplying the highest quality systems to companies across a wide range of industries since 1990. Accredited to ISO13485 and ISO9001, Ultrawave are suppliers to companies from the healthcare, medical, manufacturing and processing sectors and have developed a broad portfolio of products tailored to different applications. The hygea™ range of HTM compliant, validated ultrasonic cleaners are used in primary care and CSSD environments, decontaminating surgical instruments in both the NHS and the private sector. In addition, Ultrawave are approved suppliers to a number of medical device manufacturers and work closely with renowned companies both in the UK and abroad. Used in almost any application, ultrasonic cleaning improves processing and decontamination results across a wide range of industries and environments.
United Aerospace Ferry Lane Pembroke Dock Pembrokeshire SA71 4RE +44 (0)1646686622 www.united-aerospace.com enquiries@united-aerospace.com
United Aerospace Ltd are designers, manufacturers and finishers of composite components for a wide variety of industries. We have the capability to take concepts through the entire design process, and project manage into and through full manufacture all at one location in Wales.
United Plastics Group Cwm Cynon Industrial Estate North Plateau Mountain Ash RCT CF45 4ER +44 (0)1443471200 www.upgintl.com/manufacturing nparsons@upgintl.com
UPG is an innovative global provider of product development and manufacturing solutions servicing the medical market with tooling design and construction, custom injection moulded plastic components, semi-finished sub-assemblies to multifaceted fully finished final products. UPG manufactures components and assemblies for an array of medical markets and products, Class 1 and Class 2 medical devices. Highly cosmetic and fully functional parts. This includes minimally invasive surgical devices; respiratory, anaesthesia and catheter devices; infusion, diagnostic instruments and devices; and patient monitoring systems. UPG global expertise and processes are tailored to meet the stringent demands for today’s healthcare products.
37
PROFESSIONAL SERVICES Abel & Imray 3 Assembly Square Britannia Quay Cardiff CF10 4PL +44 (0)2920 894200 www.patentable.co.uk ai@patentable.co.uk
Abel & Imray is a leading firm of Patent and Trade Mark Attorneys handling all aspects of intellectual property including patents, trade marks and designs. We have expertise in all fields of medical and related technology. Our team of biotechnology and chemistry specialists has particular experience in diagnostics, gene therapy, drug delivery systems, protein engineering, pharmaceuticals and combinatorial chemistry. We have extensive experience of medical imaging technology and medical devices, including mechanical, optical and electronic medical devices. Our professionals have particular skills in the protection and exploitation of intellectual property relating to those fields, as well as experience in management and development of intellectual property portfolios.
ARP Associates Glen Rosa Llanellen Abergavenny Monmouthshire NP7 9HF +44 (0)7713484870 www.arpaltd.co.uk arpayne@arpaltd.co.uk Twitter: @alisonrpayne
Run-Grow-Transform. From short-term projects to long-term mentoring, ARP Associates Ltd can offer you help with your business. We can help you to develop a clear direction for your company and put that strategy into action, whether this be through new marketing plans, staffing structures or new revenue streams. With over twenty years’ experience in running healthcare businesses, we specialise in helping medium-sized enterprises that are keen to get to the next stage. Our approach is empathetic, professional and committed. We know that you are the experts in your business, but we also know that a fresh perspective can help highlight opportunities for positive change.
Awen Consulting Dylan Thomas Centre 1 Somerset Place Swansea SA1 1RR +44 (0)1792532201 www.awenwales.com m.heuberger@awenwales.com
Awen Consulting is the consulting arm of Awen Cymru. We provide a range of project managed services to the medical device community to solve problems at every level and develop prototypes through to market. l
Product Design [Electronic, Software, Mechanical] Intellectual Property (IP) Advice l Range of Core Research Services l Clinical Services l Product Approval Advice l Specialist Market Research l Manufacture Partnering We are currently developing our own directional disposable illumination that is electric and battery waste EU directive compliant, which is currently being prototyped and will be ready for market soon. l
BIC Innovation Pencoed Technology Centre Bridgend CF35 5HZ +44 (0)1656861536 www.bic-innovation.com info@bic-innovation.com
38
With offices in Pencoed Technology Centre – South Wales, Parc Menai – Bangor, and the City of London, BIC Innovation is Wales’ leading innovation services business, undertaking wide ranging UK and international project work for clients. With an experienced healthcare team in new product development (NPD), strategic innovation, design, sales & marketing and performance improvement, we can help you drive your healthcare business forward. We offer: l
Strategic Innovation and Development
l
Marketing Research
l
International Sales & Marketing Management
l
Technology & IPR Exploitation
l
NPD Processes and Management
l
Financial Management Services
l
Performance Improvement
l
Total Project Management
l
Skills for Change
Annual Review & Directory 2012
Broomfield & Alexander Broomfield & Alexander are Wales’ leading independent firm of accountants and professional advisors, based in Cardiff, Newport and Swansea. We provide financial and commercial services to owner managed businesses, mid to large corporates, medical practices, private clients and professional practices. Ty Derw Lime Tree Court Cardiff Gate Business Park Cardiff CF23 8AB +44 (0)2920549939 www.broomfield.co.uk info@broomfield.co.uk
Services include: l
Audit and assurance including internal, statutory and specialist audits
l
Business services including account preparation, book-keeping and VAT returns, company secretarial services and payroll bureau
l
Personal tax services such as self-assessment, P11ds, and corporation tax
l
Business development including strategic planning and profit improvement
l
Corporate finance including business planning, investment raising, grant finding, exit and retirement planning, mergers and acquisitions , business valuations and due diligence
l
Specialist tax planning such as tax restructuring and individual wealth management
l
HR consultancy on employment issues
l
Marketing consultancy
l
Independent financial advice through an Independent Financial Advisor network
l
New starts
l
International businesses
l
Social housing associations
l
Charities and not-for-profit
l
Professional practices
l
Medical practices (AISMA)
Cardiff Medicentre Heath Park Cardiff CF14 4UJ +44 (0)2920757744 www.cardiffmedicentre.co.uk enquiries@cardiffmedicentre.co.uk
Cardiff Medicentre is a dedicated medtech and biotech business incubator located on the University Hospital of Wales campus. The latter extends across 53 acres, provides a working base for over 4,000 people and is home to Cardiff University’s School of Medicine. The Cardiff Medicentre was officially opened in 1994 and was the first incubator of its kind in the United Kingdom. It provides high quality office and laboratory accommodation comprising of 32 units ranging from 284 sq ft to 1,045 sq ft. Low-cost desk leasing facilities are also available to encourage entrepreneurs to enter the Cardiff Medicentre community whilst writing business plans and raising finance.
Contact Innovation Contact Innovation, through its dedicated specialists, provides integrated strategic marketing, innovation and graphic design services to SMEs, start-ups and business support organisations. Our services are aimed at reducing financial risk, time to market and improving the quality of products and the chances of success for our clients. We do this by using up-to-date techniques as well as those that are tried and tested, combining them to provide a truly bespoke service for every client. Contact Innovation has extensive experience in the area of knowledge transfer - the transfer and utilisation of knowledge and technology developed by university and public research establishments for the benefit of private sector companies. 7 Schooner Way Atlantic Wharf Cardiff CF10 4DZ Wales +44 (0)2920473456 www.contactinnovation.com gtudor@contactinnovation.com
Contact Innovation has worked for both private sector manufacturers, a university, and a government funded advisory service.
39
Designworks Windsor Unit 2 The Windsor Business Centre Vansittart Estate Windsor Berks SL4 1SP +44 (0)1753842404 www.designworksgroup.net jez@designworkswindsor.co.uk
Designworks is a product design and development company. We have been in business for over twenty years, and specialise in delivering new products from concept through to production in many fields ranging from FMCG items, automotive, child care and medical. Our in house team can develop concepts via the following methods: l
Insightful discovery work identifying market opportunities, and uncovering consumer usage habits
l
Concept sketches and computer generated imagery
l
Styling options and ergonomic studies via computer generated imagery and scale models
l
Outline CAD layouts of new concepts for feasibility and cost studies
l
Electronics design, prototypes and sampling
l
Working prototypes/models for demonstration and trials. Biocompatible materials available
l
Documented manufacturing suitable information
l
Assist in clinical trials procedures via DW preferred partners
Designworks is happy to assist in any of the above on an individual basis, or on a complete project solution. We provide fixed prices where possible. And assign all IP that is derived from commissioned work to the client.
E2L Products 19 White Swan Court Priory Street Monmouth NP25 3NY +44 (0)1600714856 www.e2l.uk.com info@e2l.uk.com
Engineering product designers with electronic, mechanical and industrial design skills, providing consultancy design services, joint venture development and proprietary products. Focussed on design simplicity, alternative thinking and functional necessity. ISO 9001:2008 certified. Track record of product development collaboration with NHS. Owners of ‘MegaBee’ frequent use writing tablet for extreme motor loss and spinal trauma sufferers. R&D resource for new products/inventions requiring electronic and mechanical engineering inputs, product rescue and ongoing development. Expertise with portable systems, battery operated, low power systems, wireless communications. Products are all sold through third party agents or joint venture partners; consequently non-market sector specific. Actively involved in various health areas including AAC, anaesthesia, urodynamics and orthopaedics.
Electronic Motion Systems Penllergaer Business Park Swansea SA4 9HL +44 (0)1792543041 www.electronicmotionsystems.com jeff.clifford@ electronicmotionsystems.com
Electronic Motion Systems is a provider of integrated design & manufacturing services. A highly flexible, customer focussed UK design & manufacturer in printed circuit board assembly, mechanical assembly, full product build and test capability with additional capability in wire bonding and die attach. Manufacturing facility based in Swansea which has a class 10,000 clean room with full FA capability to support our highly accredited quality standards.
Excalibur Group Berkeley Square House Berkeley Square Mayfair London W1J 6BD +44 (0)2078877642 www.excalibur-group.co.uk info@excalibur-group.co.uk
40
Excalibur Group is the medical science investment house founded by Sir Chris Evans. It has €0.5bn of funds under management and specialises in investing venture capital in the medical sciences sector.
Annual Review & Directory 2012
Finance Wales Oakleigh House Park Place Cardiff CF10 3DQ +44 (0)8005874140 www.financewales.co.uk/ earlystage info@financewales.co.uk
Finance Wales can invest up to £1 million seed and early stage development capital in exciting technology-based businesses and we can invest over a number of rounds. Our early stage team has a wealth of industry expertise and experience as well as a strong network of co-investment partners. We can work with you and potential co-investors to structure an investment that’s right for your business. Finance Wales specialises in technology venture investment and has invested £9.5 million in its portfolio of 14 life sciences companies in the last 3 years. So, if you’re developing and commercialising novel IP, talk to Finance Wales.
Fulcrum Direct Cardiff Business Technology Centre Senghenydd Road Cardiff CF24 4AY +44 (0)2920647019 www.fulcrumdirect.co.uk liz@fulcrumdirect.co.uk
We provide effective business planning and marketing services designed to help companies achieve tangible results. Specialising in small and SME companies in the biosciences and technology sectors, our mission is to provide high quality support using professionally qualified and experienced marketing associates to ensure profitable business results for our clients. You will benefit from our independent, cost effective approach to helping you understand your markets, maintain a pipeline of high quality prospects and develop an integrated approach to marketing communications which maximise your sales, whatever channels you chose.
Fusion IP The Sheffield Bioincubator 40 Leavygreave Road Sheffield S3 7RD +44 (0)1142755555 www.fusionip.co.uk nataliewilkinson@fusionip.co.uk
Fusion IP owns the rights to 100% of university-owned research generated at two of the UK’s leading universities – The University of Sheffield and Cardiff University. These exclusive partnerships enable us to develop some of the world’s most advanced and exciting science, in fields as varied as clean energy, electronics, engineering and medicine; turning world class research into valuable businesses through the creation of a portfolio of companies.
Geldards LLP Geldards LLP is one of the UK’s leading commercial law firms with offices in Cardiff, Derby and Nottingham providing a full range of legal services to clients in the healthcare and life sciences sectors.
Dumfries House Dumfries Place Cardiff CF10 3ZF +44 (0)2920238239 www.geldards.com lifesciences@geldards.com
The firm’s dedicated healthcare and life sciences team has a strong track record in dealing with medical technology, knowhow licensing, research and development collaborations, commercial contracts and commercial and intellectual property disputes. Geldards’ clients include start ups, SMEs, universities, hospitals, medical devices companies and large multi-nationals. What others say: “It’s a huge pleasure to work with such professional guys”. Gerwin Bouillon, Global Head of Product Defense, Bayer CropScience AG. “This Cardiff firm continues to impress with the strength of its IP offering. Its solicitors deal with trade mark and patent protection, brand advice and a variety of transactional and licensing matters on behalf of household names.” Chambers & Partners 2011. “Geldards spent time to ensure that they fully understood our business and our requirements. They provided a highly professional and prompt service which completely met our needs”. Clinical Diagnostix Limited.
41
Giles Insurance Brokers Unit 3 Magden Park Green Meadow Llantrisant CF72 8XL +44 (0)1443 502500 www.gilesinsurance.co.uk paul.norman@gilesinsurance.co.uk
Giles Insurance Brokers Ltd are specialists in the lifescience sector, acting for more than 200 clients in the UK and overseas from university spin-outs to main market-listed companies, including companies involved in the research, development and supply of pharmaceutical and medtech products, CROs and related service providers. We are proud to be sponsors of both OBN and the BIA. We offer a range of specialist insurance products and services, including: l
Global clinical trials
l
Pharmaceutical and medical product liability
l
Bio-medical error & omissions/professional indemnity
l
Medical malpractice
l
Intellectual property litigation & protection
l
R&D and supply chain protection
l
Marine and goods in transit
l
Directors’ and officers’ indemnity
Grahame Guilford and Company Ty Mawr Pheasant Walk Clos-y-Talcen, Pen-y-Fai Bridgend CF31 4DU +44 (0)1656667997 guilfordco@btinternet.com
Consultancy, business planning and development services within the life science sector primarily. Services to the higher education sector on commercialisation of research and technology transfer.
GX Group GX Design Engineers are one of the UK’s leading technology and innovation companies. We offer our clients, and specifically those in the medical and scientific sector, a multidisciplinary and holistic approach to new product design and development.
The Mayfield Usk NP15 1SY +44 (0)1291673437 www.gxgroup.com claire.banks@gxgroup.com
We are fascinated by the multi-faceted challenges presented by imaginative clients – you know exactly where you want to be and we take terrific professional pride in helping you get there. Our engineering excellence and skilful differentiation delivers a competitive product to maintain or grow your market share whilst setting you apart from your competition. Our in-house team offers a complete skill set including electronic hardware and software design, industrial and mechanical engineering, as well as specialist areas such as optronics and microfluidics. No matter how ambitious your original idea, or how challenging the issues, we have the technical skill, creative talent and sheer commercial know-how to make it possible!
Hugh James 114-116 St Mary Street Cardiff CF10 1DY +44 (0)2920224871 www.hughjames.com cardiff@hughjames.com
42
Hugh James provides expert corporate legal advice to companies and investors in the life sciences sector. The firm has an established reputation as a market leader having advised major Welsh institutional investors and corporates on numerous life science investments, acquisitions, intellectual property issues and commercial agreements. Our team’s approach is to give commercially focused and practical advice and to understand your business. We can add real value through our comprehensive knowledge of your sector, which we have gained by advising a complete range of companies from start ups and spin-out ventures to major industry leaders and AIM listed international organisations.
Annual Review & Directory 2012
Hunter International Associates (HIA) Windsor Business Centre Pentre Churchstoke Powys SY15 6SU +44 (0)1588620062 www.hia-trade.com jh@hia-trade.com
HIA Ltd has been working the Chinese medical sector for ten years and has developed relationships with a range of Chinese companies involved with manufacture, logistics, distribution, regulatory compliance, and research and development. These companies wish to co-operate with counterpart UK businesses in technology transfer. Recent initiatives by both the UK and Chinese governments have opened up many opportunities for UK products and services, particularly high technology and equipment/devices which relate to an increasingly elderly community. Smaller UK companies often lack the resources, experience, expertise and contacts needed to succeed. Additionally the commitment required from senior management can affect the company’s focus on core business. The range of services offered by HIA Ltd can support market entry and development and feedback from our associates in China can help to identify specific opportunities.
Hyderus Cyf. 34 Heol Maindee Cwmfelinfach Ynysddu Casnewydd NP11 7HR +44 (0)1495200321 info@hyderus.com
Hyderus is a strategic communications consultancy specialising in: l
Influencing treatment decisions and patient empowerment across Europe
l
Building specialist and general understanding of public health issues
l
Communicating development and developing country health matters to policy makers, specialist audiences and the general public
l
Helping Welsh organisations to communicate with stakeholders in Wales and throughout the world
Within these disciplines we provide strategic consulting, qualitative market research (through a partner company), commissioning and management of quantitative research, stakeholder relations and public affairs in Wales and the UK, internal communications, media and public relations in Wales and the UK, media and influencer relations in over 50 countries, and crisis planning and management. Hyderus is currently invoved in a market research project with PhRMA India whereby we help to identify specific partnerships whom the company would work with in order to improve access to healthcare in India. inovia inovia provides a foreign filing platform, inovia.com, to simplify and reduce the cost of PCT national stage entry, European validation and patent translations. Our client base consists of companies, law firms and universities seeking international patent protection. 928 Broadway Suite 1100 New York NY 10010, USA +44 (0)2033704977 www.inovia.com candida.jaco@inovia.com Twitter: @inoviaIP
Isca Healthcare Research HIll House Belmont Hill Caerleon NP18 1JX +44 (0)1633423641 pw@iscahcr.co.uk
ISCA HEALTHCARE RESEARCH is a specialist consultancy providing expert services in the development of medical devices, pre-clinical / clinical device development, medical device clinical trials and clinical regulatory documentation. This expertise is based on >20years’ experience working with medical devices and their clinical validation in the UK, Europe and Internationally. ISCA HEALTHCARE RESEARCH has extensive experience in the following areas: medical device development and clinical validation; medical device pre-clinical / clinical trials and project management; clinical trial documentation; MHRA submissions; clinical literature reviews for regulatory submissions; pre-audit review of clinical regulatory submission documentation; and medical and study report writing.
43
Jara Consulting 95 Allt-yr-Yn Avenue Newport NP20 5DE +44 (0)1633784344 john@jaraconsulting.com
Jara Consulting develops and delivers bespoke programmes for technology and engineering companies to improve their sales and marketing performance: l Marketing strategy and tactics – formulation and implementation l New business sales improvement – performance monitoring, lead generation, qualification, quotation and conversion.
KPIs, management and coaching l Customer and account management strategies and implementation programmes for managing, retaining and growing
the customer base Marks & Clerk LLP 20 Imperial Square Cheltenham Gloucestershire GL50 1QZ +44 (0)1216342318 www.marks-clerk.com cheltenham@marks-clerk.com
Marks & Clerk LLP is the leading and largest firm of patent and trade mark attorneys in the UK. Originating in the Midlands, Marks & Clerk has a strong regional focus with an established office in Cheltenham, covering the whole of the South West and Wales. We offer a comprehensive range of intellectual property services covering patents, trade marks, designs and copyright. We are highly experienced in all fields of medical technology; with dedicated biotech and chembio teams having extensive experience in genetics, pharmaceuticals, medical devices, medical implants and bio- diagnostics. Our widely acclaimed annual biotechnology report continues to generate considerable interest from our clients and contacts worldwide as well as the media. Marks & Clerk acts for all types of client, from corporations through to university spin-outs and start-ups, SMEs, individuals and leading academic institutions. We are consistently ranked in the top tier for patents and trade marks in the UK by Managing Intellectual Property (MIP), The Legal 500 and Chambers directories.
MEDDEV QA 5 Hillside Drive Cowbridge Vale of Glamorgan CF71 7EA +44 (0)1446774948 +44 (0)7714288232 medicaldevices@aol.com
Product development planning; initial quality and regulatory gap assessments and pre-assessment audits; part-time quality management services; quality systems and capa training; implementation and upgrading of quality systems for iso 9001, iso 13485, fda 21 cfr 820 and the eu medical device directives; device classification queries; preparation of technical files and design dossiers for ce marking; liaison with regulatory bodies; field safety corrective action management, ec vigilance reporting and fda mdr reporting; liaison with notified bodies and other regulatory bodies; internal auditing and vendor quality system auditing; ongoing qa/ra support; eu authorized representative services for non-eu based operations.
MxPD Quantum House 25 Commercial Road Taibach Port Talbot SA13 1LN +44 (0)1639881111 www.mxpd.co.uk joseph@quantumcad.co.uk
44
MXPD is a leading electronic medical product development consultancy that specialise in producing new and existing technologies which offer real commercial value. Our unique medical product design process delivers a full range of design support from user insight research and analysis, through to product and electronic development, prototyping and design for manufacture.
Annual Review & Directory 2012
On Screen Productions Ashbourne House 33 Bridge Street Chepstow NP16 5GA +44 (0)1291636300 www.onscreenproductions.com production@onscreenproductions.com
On Screen Productions helps ambitious health, science and technology companies to launch and promote their products and services. Our focus is the healthcare sector where we have over twenty years of experience. Our people talk the language. We understand (and are trained on) the rules and regulations. We also attract clients from other sectors that are defined by their demanding and complex subject matter and specialist professional audiences. 80% of work is EMEA and global. Proven expertise in compelling communications to motivate and educate — from strategy to execution, across the broad range of external and internal marketing, advertising, branding, digital and online services. l
l
l
Advisory boards Medical congresses l Exhibitions l Live events l Graphic design l Digital media — including iPads l CGI and animation — including complex mode-of-action
l l l l l l
Conferences and seminars Gala dinners Awards ceremonies Internal comms Brand building Webcasts and IPTV TV and video
PIA Commercial PIA Commercial Insurance We are a specialist life science, biotechnology, and healthcare insurance broker. we provide the following insurance products: The Old Fire Station professional indemnity, commercial insurance, employers and public liability, product liability, directors and officers, clinical 69 Albion Street B1 3EA trials, laboratory insurance, business legal expenses, corporate and private medical insurance. +44 (0)1216946897 www.piacommercial.com mike.cherrington@piacommercial.com
PKF (UK) LLP PKF LLP 8th Floor Helmont House Churchill Way Cardiff CF10 2HE +44 (0)29 2064 6200 www.pkf.co.uk tim.smith@uk.pkf.com
PKF (UK) LLP is a leading firm of accountants with offices in Cardiff. We provide integrated solutions to meet the needs of an organisation at every stage in its development. Best of all, we combine a local presence and personal approach with the experience and confidence of a national firm. We provide financial and commercial services to the SME market place including owner managed businesses, mid to large corporates, medical practices, private clients, charities and professional practices. Our services include: l
Audit and assurance
l
VAT advice
l
Personal tax services including self-assessment tax returns, capital gains tax advice and Inheritance tax
l
Research and development tax credit advice
l
Corporation tax returns
l
Capital allowance reviews
l
Corporate finance including business planning, investment raising, grant funding, exit and retirement planning, mergers and acquisitions , business valuations and due diligence
l
Specialist tax planning
l
Employer essentials e.g. rewarding staff, EMI share schemes, payroll
l
Corporate recovery and insolvency
45
Teamworks Teamworks is a full service design and marketing agency. Established over 25 years ago in Cardiff, the 10 person company comprises creative designers, web developers, marketers and research specialists. 7 Schooner Way Atlantic Wharf Cardiff CF10 4DZ +44 (0)2920473455 www.teamworksdesign.com studio@teamworksdesign.com
Our dynamic team has extensive experience working with a range of public and private sector organisations, of which many operate within life sciences. Service Portfolio: web, branding, print, advertising, exhibition, packaging, SEO, social media, usability, feasibility studies, campaign development and management, PR, direct mail.
Teamwork Technology Services Institute of Life Science Singleton Park Swansea SA2 8PP +44 (0)8000803003 www.teamworkict.com info@teamworkict.com Twitter: @teamworkict1
Teamwork Technology Services Limited is an established independent ICT consultancy and managed services company based in South Wales but with its client base spanning the UK. The company is active in the biotechnology, pharmaceutical and healthcare sectors and has extensive experience working with SMEs across a wide range of sectors advising them of the most appropriate ICT for their business. Teamwork is a principal provider for delivering consultancy services for the Welsh Government via the e-Business ICT programme as well as providing independent consultancy services to growing SMEs. Teamwork is currently developing e-security and e-health areas of the business.
Triteq The Innovation Centre Station Road Hungeford Berkshire RG17 0DY +44 (0)1488 684554 www.triteq.com angela.hobbs@triteq.com Twitter: @triteq
Triteq is at the forefront of technology in product design combining creativity, collaboration, knowledge and experience. We provide a comprehensive range of industrial, hardware and software services in concept, design, development and consultancy. We work in partnership with our clients to bring new products to market and to improve the capabilities of existing ones.
UK Healthgateway 23 Cae Rex Llanblethian Vale of Glamorgan CF71 7JS +44 (0)7900570172 www.ukhealthgateway.com jon@ukhealthgateway.com
UK Healthgateway is the specialist UK health market entry expert. We offer: l
Distributor search
l
Regulatory certification (CE all grades)
l
Market research
l
Clinical product assessment & trials
l
Commercial planning
l
Clinical PR and product advocacy
l
Legal and financial planning
Our network of expert associates are the best in the business and our clients benefit from an unrivalled contacts network and NHS process understanding. Whether your product is equipment, device, consumable or pharmaceutical, we will make your market entry successful.
46
Annual Review & Directory 2012
Urquhart-Dykes & Lord LLP Churchill House Churchill Way Cardiff CF10 2HH +44 (0)2920642150 www.udl.co.uk cardiff@udl.co.uk Twitter: @UrquhartDykes
In an increasingly competitive world and global market, the protection of intellectual property is vital to commercial success. Particularly in the medical sector where many of the major players are based in the US or Japan, Welsh innovators need to keep ahead of the game. UDL is one of the largest firms of patent and trade mark attorneys in Wales. Through its many years of experience working in the medical field, UDL has the expertise to advise you on all aspects of patents, trade marks and designs. To find out how we can help you protect some of your most valuable assets, visit our website or contact Mark Davies or Michelle Ward.
Waterside Consulting Waterside Consulting Ty Blaenant Ddu, Felindre SA5 7ND +44 (0)1792793866 www.waterside-consulting.co.uk sueh@waterside-consulting.co.uk
Sue Heatherington of Waterside brings many years of experience as an NHS CEO both in England and Wales. She now has a creative practice in leadership development for leaders and senior teams in life science, medical technology and healthcare organisations. With a passion for healthy leadership as a foundation for innovative organisations and productive collaborations, Sue is a professional coach, thinking partner and facilitator. She particularly relishes working with those who want to step beyond their current boundaries in making a difference to the health and wellbeing of patients. Sue is a Fellow of the Royal Society of Medicine.
Wentwood Medical Wentwood Medical provides sales and marketing expertise to the healthcare, biotechnology and pharmaceutical sectors in The Manse the UK and Europe. Tabernacle Lane Our Services Include: Llanvaches Cadidcot l Start up Company Sales, Marketing and Business NP26 3BL l Operational Brand Management Services +44 (0)1443 482 482 l Strategic Brand Planning Services www.wentwoodmedical.com l Strategic Brand Planning Services scottforde@wentwoodmedical.com l Warehousing, Storage, Distribution Services Wentwood Productions provides a wide range of communication and promotional services to companies and organisations in the UK, Europe and around the world. Our Services Include: Integrated Marketing Campaigns l Concept Development for Products and Services l Video and Photography l Design and Print l Electronic Media l Writing l Live Events l
Westnine Services 221 Canford Lane Bristol BS9 3PD www.westnineservices.co.uk greg.smart@westnineservices.co.uk
Westnine is a project management consultancy focussed on e-health, telehealth and wireless healthcare. Westnine is uniquely placed to support organisations in delivering innovation and delivering results in wireless healthcare projects. Westnine can help your project meet its objectives. We can help: identify funding opportunities for product development, R&D or trials, develop funding applications for projects which will take your business forward, manage projects to develop new capability and build clinical evidence, provide specialist wireless development expertise, achieve regulatory approval for your product, and bring your product to market.
47
Withers & Rogers LLP 1 Redcliff Street Bristol BS1 6NP +44 (0)1179253030 www.withersrogers.com admin@withersrogers.com
Withers & Rogers LLP is one of the leading intellectual property law firms in the UK and Europe. We specialise in the protection and enforcement of intellectual property rights including patent protection for inventions and trade mark registration for brands (and design rights, registered and unregistered) for products. We act in patent, trade mark and design right infringement proceedings. With more than 50 experts with specialist experience in many industry sectors, we enjoy working closely with our clients so we can advise them on the best intellectual property strategy to meet their needs. Our life sciences and chemistry principal practice group is one of the largest in Europe, with a depth of expertise and experience in the chemical, biochemical and pharmaceutical industries, as well as in academic research. Our highly skilled medical device specialist practice group is supported by attorneys from across our principal practice groups.
Wynne-Jones IP Temple Court 13a Cathedral Road Cardiff CF11 9HA +44 (0)29 2078 6535 www.wynne-jones.com email@wynne-jones.com Twitter: @ip_expert
Wynne-Jones IP is a long established firm of Chartered and European Patent and Trade Mark Attorneys based in Cardiff and Cheltenham. We act for a large number of Welsh clients, and we have an excellent reputation locally, nationally and internationally. Our client list includes private individuals, multi-nationals, large technology-based companies, SMEs and universities. We specialise in intellectual property (IP) services, including full spectrum patent services in life sciences, healthcare, medical devices, medical detection techniques, biotechnology, chemistry and nanotechnology. IP plays a vital role in the modern business environment. Whether it be protecting and realising the value of inventions, proprietary technology, brands or original designs, getting the right advice is key. We provide a premium quality service and our goal and focus is always on the business needs and objectives of the client. Our attorneys have extensive experience in patents, trade marks, all aspects of IP licensing and enforcement, and IP audits.
xénos – The Wales Business Angel Network Axis 3, Axis Court Riverside Business Park, Mallard Way Swansea Vale Swansea SA7 0AJ +44 (0)2920338144 www.xenos.co.uk info@xenos.co.uk
xénos - The Wales Business Angel Network brokers deals between business angels (high net-worth private individuals) and businesses and/or individuals seeking investment. The network is part of the Finance Wales Group and has facilitated over £25 million of private investment into well over 200 Wales-based businesses since its formation in 1997. xénos investors fund all stages of development from seed-corn and early stage, through to expansion, acquisition and turnaround. The network has more than 150 registered investors seeking investment-ready opportunities.
Welsh Government - Life Sciences Team The focus of the Welsh Government’s Life Sciences Team is on business growth and commercial success. We are co-ordinating a strategy for the life sciences sector in Wales that will enhance and develop our existing clusters of expertise and facilitate the creation of an ecosystem which is vibrant and dynamic. The Life Sciences Team has access to a range of funding mechanisms and related programmes and infrastructure to support the location, development and growth of businesses in Wales. We also have joined up routes across Government Departments to support academia and the NHS to pursue and share research excellence to benefit the economy and the people of Wales. Llys-y-Draig Penllergaer Business Park Penllergaer Swansea SA4 9NX +44 (0)3000603000 www.business.wales.gov.uk lifesciences@wales.gsi.gov.uk
48
Annual Review & Directory 2012
MEDIWALES INNOVATION
MediWales is delighted to announce a daytime medtech conference to complement our annual Innovation Awards dinner.
2012 The Conference Delivered in partnership with One Nucleus’ flagship London event Genesis, with collaboration from other international partners across the UK. Presentation themes including: clinical access for product development, NHS procurement, regulatory issues, funding and finance, and international trade.
11 December 2012 A day to remember. A night to celebrate.
The Awards Get recognition in the life science sector for impressive export figures, an NHS collaboration, your high potential start-up, or an innovative product or service. Apply to the MediWales annual Innovation Awards. Don't miss out! Contact MediWales for more information about awards entry and sponsorship. debbie.laubach@mediwales.com, +44 (0)29 2047 3456
London’s premier Life Science & Healthcare networking conference
genesis2012 13 December 2012 Queen Elizabeth II Conference Centre Westminster, London, UK onenucleus.com/genesis 49
EXTENSIVE EXPERTISE IN
EXTENSIVE EXPERTISE IN
Contact us: t :+44 (0) 2920 744852 e-mail : wai@cf.ac.uk www.anaesthesiainnovation.org
Contact us: t :+44 (0) 2920 744852 e-mail : wai@cf.ac.uk www.anaesthesiainnovation.org
Dept. of Anaesthetics, Intensive Care and Pain Medicine, Heath Park, Cardiff University, Cardiff CF14 4XN
Dept. of Anaesthetics, Intensive Care and Pain Medicine, Heath Park, Cardiff University, Cardiff CF14 4XN
United Kingdom
INDUSTRY
Well informed. Well read.
Production and distribution is supported by partners EXTENSIVE including: ● iNets South West Biomedical ● MediWales ● Medilink East Midlands ● SEHTA ● Medilink West Midlands ● Medilink Yorkshire & Humber ● ABHI ● HealthTech and Medicines
KTN
● One Nucleus ● Scottish Enterprise ● Medilink North West
Distributed to 38,000 named individuals with an estimated total readership of 100,000
EXPERTISE IN
EXTENSIVE EXPERTISE IN
News, developments and analysis from the magazine at the heart of the UK Lifescience Industry. Published by MedilinkUK and its partner organisations who are in daily contact with leading innovators, UK Lifescience Industry provides: ● Cutting edge analysis ● Leading scientific opinion ● A perfect platform for advertising ● Print and digital formats
A MEDILINKUK PUBLICATION Contact us: t :+44 (0) 2920 744852 e-mail : wai@cf.ac.uk www.anaesthesiainnovation.org
Make sure you book your place Dept. Contact: of Anaesthetics, Intensive Care and Pain Medicine, ruth@uklifescienceindustry.com Heath Park, Cardiff University, Cardiff CF14 4XN
or call +44(0) 29 2047 3456
IP for the Life Sciences • Patents
• Trade Marks
Offices in Cardiff and Cheltenham
Contact us: t :+44 (0) 2920 744852 e-mail : wai@cf.ac.uk www.anaesthesiainnovation.org Tel: +44 (0) 2920 786535
Email: email@wynne-jones.com Dept. of Anaesthetics, Intensive Care and Pain Medicine, Web: www.wynne-jones.com Heath Park, Cardiff University, Cardiff CF14 4XN
Annual Review & Directory 2012
Excellent. Professional. Personable. Don’t take our word for it. (Source - Legal 500) Geldards is one of the country’s leading regional law firms. Our clients, in both the private and public sectors, trust us to give them high quality legal advice that is practical, commercially-minded and value for money.
lifesciences@geldards.com
Our dedicated healthcare and life sciences team has a strong track record in dealing with medical technology, know-how licensing, research & development collaborations, commercial contracts and commercial & intellectual property disputes.
www.geldards.com 0844 736 0006
+ WWW.PDRONLINE.CO.UK
MEDICAL DEVICE + EQUIPMENT DESIGN SPECIALISTS Ê PRODUCT DESIGN Ê USABILITY + COMPLIANCE STUDIES Ê GRAPHIC DESIGN + BRANDING Ê PACKAGING DESIGN Ê INNOVATION MANAGEMENT Ê USER OBSERVATION LABORATORY Ê PROTOTYPING + RAPID LOW VOLUME MANUFACTURE Ê KNOWLEDGE TRANSFER Ê RESEARCH THE NATIONAL CENTRE FOR PRODUCT DESIGN + DEVELOPMENT RESEARCH
PDR UWIC WESTERN AVENUE CARDIFF UK CF5 2YB
T +44 (0)29 2041 6725 F +44 (0)29 2041 6973 E INFO@PDRONLINE.CO.UK
+ WWW.PDRONLINE.CO.UK